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ABSTRACT 
H2S is a colorless gas with a strong “rotten egg” odor. While at physiological 
concentrations, H2S is a vital gasotransmitter; exposure to high concentrations can result in 
extreme intoxication, leading to acute death within minutes. H2S poisoning is a leading cause 
of occupational deaths. Among toxic gases, H2S follows only carbon monoxide poisoning as 
a leading cause of death. There is also concern for this chemical to weaponized as it is easy 
to make from household chemicals found in local general stores. H2S can cause severe 
neurodegeneration and neurological sequelae post exposure. There is no ideal treatment for 
acute H2S-intoxication in humans. Our laboratory has characterized two translational mouse 
(C57) models to evaluate potential drugs for prevention and treatment of H2S-induced 
toxicity, and potentially elucidate the molecular mechanisms involved in the pathophysiology 
of H2S poisoning. We observed that H2S consistently induced seizures and knockdown in the 
mice, and induced motor deficits, neurochemical alterations, neuroinflammation, oxidative 
stress and neuropathology. Our data demonstrated that Cobinamide dose and time 
dependently reduced the behavioral deficits, neuroinflammation, neurochemical changes, 
oxidative stress and the histopathological changes induced by H2S. Additionally, our studies 
show promise for Midazolam as an antidote for treatment of H2S-induced neurotoxicity as it 
reduced H2S-induced mortality by 90% when given prior H2S exposure, and reduced 
mortality induced by H2S by 50% when given during the exposure.  Midazolam administered 
pre-exposure prevented clinical signs, motor deficits, and histopathological lesions induced 
by H2S. Collectively, we have validated and characterized a translational mouse model of 
H2S-induced neurotoxicity, and used the model to demonstrate efficacy of cobinamide and 
midazolam as countermeasures against H2S-induced neurotoxicity.  
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CHAPTER 1 
GENERAL INTRODUCTION 
 
Dissertation Organization 
The alternative format was chosen for this dissertation and consists of manuscripts 
that have either been published or are in preparation for submission. There is a general 
introduction containing a literature review of hydrogen sulfide, three research chapters in the 
format of their corresponding journals, and a general conclusions/future directions section. 
Each research chapter contains references in the format of the journal it was or will be 
submitted to. The introduction, literature review, and conclusion sections have the references 
combined at the end of the thesis.  
Chapter 1, The Background and Literature Review section provides an in-depth 
review of current literature regarding hydrogen sulfide-induced neurotoxicity; providing an 
overview of hydrogen sulfide, sources of hydrogen sulfide, human health effects, current 
treatments, animal models currently in use, molecular mechanism of action, and potential 
therapeutic strategies.  
Chapter 2 is a research chapter describing the mouse model characterized and 
validated in our laboratory. This chapter has been accepted and published in the journal 
Annals of New York Academy of Sciences. Chapter 3 is a manuscript that is currently under 
revision for publication in Annals of New York Academy of Sciences. It reveals 
Cobinamide, a therapeutic compound that binds hydrogen sulfide, prevents neurotoxicity and 
neurodegeneration induced by hydrogen sulfide. Chapter 4 is currently being prepared to be 
submitted to the Journal of Medical Toxicology. This chapter outlines studies investigating 
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the therapeutic potential of an anti-seizure medication, Midazolam, as a therapeutic for 
treatment of hydrogen sulfide-induced neurotoxicity.   
For this dissertation, the experimental data and results were obtained by the author 
during the course of her PhD study in the Interdepartmental Toxicology Graduate Program 
under the supervision of her major professor, Dr. Wilson K. Rumbeiha at Iowa State 
University. 
Introduction 
Hydrogen Sulfide  
Recently hydrogen sulfide (H2S) has been identified as an endogenous signaling 
molecule1, 2. However, historically, H2S is well known as a toxic gas and as an environmental 
and occupational hazard3-7. H2S is a clear, flammable gas that has a strong “rotten egg” odor. 
It is a lipophilic molecule that can readily pass through membranes without the need for 
specific transporters8. Increasing concentrations of H2S exposure manifest diverse toxic 
effects in humans; these can range from mild irritability of the eyes and respiratory tract to 
death within minutes of exposure3, 9. Due to its wide use as a by-product in many industries, 
most commonly the oil and gas industry, it is the second most common cause of fatal gas 
inhalation in an industrial setting5, 10. It is also listed as a chemical of interest by the 
Department of Homeland Security, as these and H2S storage facilities could be potential 
targets for terrorists, especially those located in highly populated areas11, 12. Currently, there 
is no ideal treatment of H2S-induced neurotoxicity, particularly in the field. This thesis 
summarizes extensive work on development and evaluation of mouse models of H2S induced 
neurotoxicity and use of these models for evaluation of potential therapeutics for H2S-
induced intoxication.  
 
3 
	  
Physiological Sources and Role 
H2S is an endogenously produced signaling molecule in human tissues, actively involved 
in neuromodulation8, 13, 14.  In vivo, H2S can be produced via enzymatic and non-enzymatic 
pathways. There are two main enzymes actively involved in the synthesis of H2S from amino 
acid L-Cysteine; cystathionine B-synthase (CBS) and cystathionine g-lyase (CSE), as shown 
in Figure 18, 14. Another third enzyme, 3-mercaptopyruvate sulfurtransferase (3-MST) uses α-
ketoglutarate and L-cysteine by metabolically interacting with cysteine aminotransferase. 3- 
marcaptopyruvate predominantly found in the 
mitochondria, while the other enzymes can be 
active in the mitochondria and cytosol. A study 
investigating the distributions of these enzymes in 
the liver, kidney and brain found CSE to be more 
abundant in the liver and kidney, while CBS was 
found to be in higher concentrations in the brain15, 
16.  
Recent studies have shown these enzymes to 
be tissue specific, some tissues require both main 
enzymes (CSE and CBS) to produce H2S, while other require one or the other17. These 
enzymes have been identified globally in mammalian cells, including liver, kidney, 
fibroblasts, brain, and skin17. Metabolism of H2S occurs via oxidation in the mitochondria or 
by methylation in the cytosol and is excreted predominantly by the kidney. H2S can also be 
scavenged by methemoglobin or oxidized glutathione. H2S is also produced in the gut by gut 
microbial flora. 
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The functional role of H2S in the brain was uncovered in the early 1990s. H2S 
concentrations in the brain have been reported to be 50-160 uM18, 19. H2S has been reported 
to be involved in the regulation of intracellular signaling molecules, ion channel function, 
and the release and function of amino acid neurotransmitters20. It is possible that H2S exerts 
neuro-modulatory effects via astrocyte and microglia in the brain, as H2S has been shown to 
induce long-term potentiation (LTP) and an increase in calcium release from astrocytes. H2S 
inducts LTP via activation of N-methyl D-aspartate (NMDA) receptors, by activating 
cAMP/PKA pathway 21. Importantly H2S does not induct LTP on its own, but has strong 
enhancing effects, leading to a significant increase in NMDA current. NMDA receptors have 
been implicated in many neurological diseases, such as Huntington’s Disease, Schizophrenia, 
and Alzheimer’s disease; since H2S can enhance these receptors, it may modulate these 
diseases22.  
At physiological concentrations, H2S also exerts an effect on the inhibitory 
neurotransmitter, gamma-aminobutyric acid (GABA). GABA is the major inhibitory 
neurotransmitters in the mammalian brain, about 20-30% of all synapses employ GABA as a 
neurotransmitter20. GABA mediated inhibition is important for normal brain function, as the 
loss of this inhibition can lead to seizures and hyper-excitability20, 23. H2S has been reported 
to reduce injury of hippocampal damage from seizures by reversing the loss of GABA 
receptors via an increase in Ca2+.  
H2S has also been shown to modulate calmodulin kinase, an enzyme important in the 
regulation of Ca2+ homeostasis in neurons. It is believed that CBS, the enzyme responsibly 
for a majority of the H2S production in the brain is controlled by calmodulin kinase, which 
indicates that CBS is regulated by intracellular Ca2+ concentration. H2S is produced when 
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CBS is activated by Ca2+ which occurs during neuronal excitation, indicating a role in 
memory formation.  
Exogenous Sources of H2S and Exposure Scenarios  
There are several anthropogenic sources of H2S either by chemical or microbial action. 
Natural environmental sources of H2S include volcanoes, marshes, hot springs, and 
underwater thermal vents24. H2S can be also naturally released by anaerobic bacteria 
decomposing organic material; hence, H2S is also known as “sewer gas”25, 26. Agriculturally, 
specifically in the Midwest, H2S is responsible for many livestock and human deaths.  
Normally, H2S levels are very low in animal farms; however high concentrations can be 
released when manure pits are agitated 27, 28. H2S is also encountered in sewers and sewage 
treatment plants as bacteria breakdown organic material there as well29.  
In 2007, there were an estimated 1,134 documented acute exposure to H2S30. Although 
H2S poisoning is considered uncommon, reported deaths due to H2S are becoming more 
prevalent. From 2011-2013 there were a total of 43 victims of H2S intoxication, including 15 
suicide victims and 21 victims who were first responders31, 32. In industry, most of the H2S 
exposures occur in confined spaces. Confined spaces are particularly hazardous because H2S 
is heavier than air, it is able to settle and accumulate in small, restricted areas. H2S is a 
hazardous byproduct in crude oil and natural gas production, waste disposal and pulp and 
paper manufacturing, it is also widely used in rayon textile productions and chemical 
manufacturing. As this gas is stored in bulk at these industrial sites, there is potential for 
mass civilian exposure following catastrophic industrial accidents in any of these facilities 33, 
34. For example, civilians were exposed to high concentrations of H2S in Poza Rica, Mexico, 
where an accident led to 320 people hospitalized and 22 people dead from H2S poisoning. 
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Another incident in Kaixan, China, led to the death of 191 people from a sour gas well 
blowout that caused the release of H2S into the city.   
In recent years, H2S has been increasingly utilized as a tool for suicide32, 35, 36. The gas 
can be generated from the mixing of common household chemicals found at the local general 
store to create fatal concentrations of H2S, especially in confined spaces, such as a car or 
apartments. This process of suicide also increases the potential for secondary casualties, such 
as first responders, or family and friends of the victim.  
The fact that this chemical can be generated easily, or is readily accessible in large 
quantities in industries, highlights the potential for misuse of this chemical in the form of 
chemical warfare.. H2S was previously used in WWI as a chemical weapon, even though it 
was not very effective as it was used in an open area. The use of this chemical in a smaller 
confined spaces, such as a subway station would make it an effective chemical weapon. For 
this reason, there is a significant concern by the Department of Homeland Security about 
potential misuse of H2S as a chemical weapon, and is listed as a chemical of interest 11, 12.  
Hydrogen sulfide can also be produced via metabolic transformation of carbonyl sulfide 
(COS) in vivo. Carbonyl sulfide is a neurotoxic gas used as a grain fumigant. COS is 
metabolized physiologically via carbonic anhydrase to produce H2S, which is ultimately 
believed to be the chemical responsible for COS-induced neurotoxicity and 
neurodegeneration37-39.  
A majority of H2S induced fatalities occur in an occupational setting, specifically in 
confined spaces40, 41. Many workers and farmers in these settings are unaware of the hazard 
associated with H2S. Renewed efforts are needed to educate individuals working under these 
conditions, including site specific procedures and protective equipment knowledge.. Personal 
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protective equipment should include respiratory equipment, a gas monitor, long sleeves, and 
safety glasses. Many of the deaths associated with H2S-induced toxicity could have been 
prevented with the use of a safety monitor to alert the victims of H2S gas in their 
occupational setting7, 40.  
Human Health Effects and Clinical Toxicity  
The major route of exposure to H2S is via inhalation24, 42, 43. The main targets of H2S include 
the central nervous system, 
respiratory system, and the 
cardiovascular system5, 7, 43. 
At physiological pH, two 
thirds of H2S exists as a 
disassociated form (HS-) and 
one-third exists in the un-
disassociated form44.  Detoxification of H2S can occur via enzymatic or non-enzymatic 
oxidation to sulfate and thiosulfate in the liver. In healthy individuals, there are large 
amounts of sulfate and sulfite in the blood and urine, but low levels of thiosulfate. Because 
thiosulfate is a major metabolite of H2S, thiosulfate levels are reported to be a useful 
biomarker of H2S poisoning, especially in urine45, 46. 
Toxic effects from H2S exposure can occur from both low and high concentrations of 
H2S, and is concentration dependent rather than time dependent. H2S can be detected as low 
as 0.025 ppm due to its very strong rotten egg odor. Low levels of H2S (10-20 ppm) can 
cause irritation to the eyes, while exposure to 50-100 ppm can cause eye damage such as 
conjunctivitis. Levels around 100-150 ppm can damage the olfactory nerve, preventing 
Table	  1.	  
Table 1.  
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perception of the rotten egg odor, which allows for continued exposure to H2S without the 
victim being aware. At higher concentrations, 200-500 ppm, H2S causes pulmonary edema 
leading to respiratory distress, coughing, and shortness of breath. Levels ranging from 500-
700 ppm can lead to severe toxicity, including the “knockdown”. Knockdown is the sudden 
loss of consciousness at high levels of H2S exposure. Survivors have reported this 
phenomenon as a slightly euphoric. Many oil and petroleum industry workers have 
experienced some toxic effects of H2S; 30% percent have experienced some symptom of H2S 
toxicity, and 8% have become unconscious6, 44, 47. If H2S dissipates quickly, recovery from 
the knockdown can be instantaneous. At greater than 1000 ppm, just a few breaths of H2S 
can cause immediate knockdown and death. These health effects of H2S are summarized in 
Table 1. 
 Long-term consequences of acute exposure to high concentrations of H2S in survivors 
can range from none to persistent neurological problems; victims of H2S exposure are 
recommended to undergo neurological and neuropsychological testing for at least 5 years 
following H2S exposure41. The duration of neurological sequelae in victims of H2S toxicity 
can range from days to several months42. Neurological sequelae can include persistent 
headaches, nausea, convulsions, seizures, confusions, psychosis, memory impairment, ataxia, 
movement disorders, coma, sleeping disorders, and hearing impairment, among others7, 39, 42, 
48. Human victims of H2S poisoning who have been in a knockdown for 5-30 min are 
reported to have many of these neurological sequelae. One of the main issues associated with 
H2S intoxication is differentiating the primary effects of H2S from effects of anoxia5. The 
neurological conditions associated with H2S-induced toxicity can be a consequence of many 
effects including hypoxia from oxygen deprivation, direct interference with oxygen uptake, 
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trauma from falls, and potential direct mechanisms of H2S-induced neurotoxicity5. Seizure 
activity observed in victims of H2S poisoning can also interfere with breathing and may 
worsen hypoxia. Victims with pre-existing seizurogenic conditions appear to be vulnerable to 
H2S intoxication. For example, in one case report, a patient with neurofibromatosis with a 
history of epilepsy since childhood, developed seizures post H2S exposure. The patient had 
been seizure free for 5 years prior to H2S exposure. This case is of considerable interest, 
since the H2S or anoxia induced by H2S may lower the seizure threshold34. This case report is 
impactful as the general population includes individuals with epilepsy, making them 
potentially more susceptible to H2S-induced toxicity.  
H2S poisoning typically occurs acutely, and the manifestation of clinical signs often 
varies between individuals45. Factors that also could contribute to the variability in the toxic 
outcome include genetic variability, pre-existing conditions, and the duration of unconscious 
following a knockdown. Many victims of H2S poisoning are seemingly normal immediately 
post recovery from unconsciousness, but can relapse and develop complications 3-5 days 
post exposure.  Brain regions affected in victim of H2S poisoning include the basal ganglia, 
thalamus, cortex, and brainstem7, 43, 49-52. The deficits in motor function, memory, hearing and 
vision are attributed to dysfunction in these brain regions, but why these brain regions are 
specifically more vulnerable to H2S induced toxicity is unclear.  Fatal poisoning causes green 
discoloration of the brain, specifically in the basal ganglia and the cortex46. The exact 
mechanism leading to the neurodegeneration in these regions is also unknown. Elucidating 
these mechanisms will provide further insight into the neurotoxicity of H2S poisoning. .  
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Molecular Mechanisms of Hydrogen Sulfide Toxicity 
 The molecular mechanisms of H2S toxicity are yet to be determined. As mentioned 
above, one of the broader systemic mechanisms implicated with H2S toxicity is ischemic 
hypoxia that could be a culmination of the pulmonary edema, hypotension, and inhibition of 
cellular respiration via cytochrome c oxidase. Neurodegeneration induced by hypoxic 
ischemia has been known to occur in poisoning by cyanide, carbon monoxide, and following 
stroke among others 53, 54.  While current literature supports this idea, there is no direct link 
between H2S and the hypoxic-induced injury. The downstream molecular mechanisms 
leading to neurodegeneration have not been well characterized. Understanding the 
mechanism of toxicity will help elucidate potential therapeutic targets of H2S-induced 
neurotoxicity.  
Much like cyanide, H2S acts directly by inhibiting the electron transport chain at 
complex IV (cytochrome e c oxidase), the last enzyme prior the complex V, ATP synthase 24. 
The affinity of H2S to cytochrome c oxidase is much higher than cyanide, making it a more 
potent inhibitor of this enzyme than cyanide. Cytochrome c oxidase inhibition has been 
shown in many cellular models of H2S toxicity including human colon carcinoma cells, 
hepatocytes, liver mitochondria, human smooth muscle aortic cells, skeletal muscle cell, and 
cortical neurons 55-59. While cytochrome c oxidase inhibition by H2S is well known, its 
relevance to H2S-induced neurotoxicity is uncertain. Since the brain demands high energy, 
the depletion of cellular energy could potentially interfere with vital cellular functions; but in 
cyanide models of toxicity, ATP depletion is not necessary for the development of lesions60. 
This could be the case with H2S as well. The brain potentially could switch to anaerobic 
metabolism.  
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Given that H2S is a gasotransmitter involved in various cellular functions, the direct 
effects of H2S on neuronal cellular mechanisms needs to be investigated. Other mechanisms 
of toxicity have been proposed, but have not been well studied. Reactive oxygen species 
(ROS) and mitochondrial depolarization have been implicated in H2S cytotoxicity in 
hepatocytes 61, 62. Aside from cytochrome c oxidase inhibition, ROS formation can potentiate 
toxicity of H2S. Glutathione depletion and P450 catalyzed H2S oxidation contributes to ROS 
development 62.  
The ERK and caspase-3 dependent apoptosis pathway has also been implicated in the 
propagation of H2S-induced cytotoxicity 63. While the role of this pathway has not been 
extensively studied in H2S intoxication, activation of both ERK and caspase-3 have been 
shown in cortical neurons and smooth muscle aorta cells treated with H2S 56, 63. These ERK 
kinases have important signal transduction functions involved in cell growth, differentiation, 
and programmed cell death 56. Investigating how H2S modulates these signal transduction 
pathways may potentially lead to possible antidotes to treat H2S-induced neurotoxicity.    
H2S also causes changes in the neurochemical synthesis, breakdown, and modulation 
of neurochemical receptors leading to cytotoxicity. Specifically, H2S has been shown to 
inhibit monoamine oxidase, an important catabolic enzyme for monoamines 18. 
Catecholamines play an important role in respiratory rhythm controlled by the brainstem; an 
increase of these neurotransmitters has been suggested to contribute to the toxicity of H2S 18.  
H2S has shown to increase norepinephrine, epinephrine, and serotonin levels in different 
regions of the brain, specifically the brainstem. These changes can be a factor in increased 
respiratory frequency noted during the early stages of H2S intoxication 18, 43.  
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 Other neurotransmitters thought to be involved in H2S toxicity are gamma-
aminobutyric acid (GABA) and glutamate 59, 64. Modulation of these neurotransmitters has 
been attributed to the impairment of Na+/K+ ATPase. There is an efflux of L-glutamate after 
exposure to H2S, likely due to an inadequate supply of ATP to the Na+/K+-ATPase. 
Inhibition of the Na+/K+ ATPase reduces the efficiency of the glutamate transporter, leading 
to glutamate accumulation in the synapse 16. Glutamate neurotoxicity was shown in acute 
H2S exposure in rat cerebellar granule neurons, by activating L-type calcium channels. By 
using an N-methyl d-aspartate (NMDA) antagonist, H2S-induced neurotoxicity was 
prevented65.  H2S also has been shown to cause a reduction in the uptake of GABA, causing 
it to accumulate in the synapse as well, although the exact mechanism is unknown 13. Further 
experimentation needs to be conducted on how exactly H2S interferes with the breakdown of 
these neurotransmitters, but the alteration of these neurotransmitters could be important in 
the seizure activity observed in victims of H2S exposure.  
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 Although cytochrome c inhibition by H2S has been shown time and time again, there 
are other mechanisms of cytotoxicity that could be contributing factors to H2S-induced 
neurodegeneration 18, 42, 61, 62, 66. The mechanisms described above are depicted in Figure 2.  
Understanding these mechanisms can help identify novel therapeutic targets for treatment of 
H2S toxicity.   
Animal Model of H2S-induced neurotoxicity 
 Research has been conducted in order to understand the neurotoxicology induced by 
H2S using in vitro and in vivo models. Unfortunately, a knowledge gap still exists on the 
mechanisms and pathways of neurodegeneration leading to neurological sequelae. The 
challenges involved in developing a model have been demonstrated in many studies 
investigating H2S induced neurotoxicity. Currently, there is no perfect model of H2S-induced 
neurodegeneration.  
 A key study conducted by Lund et al. highlighted neurodegeneration in rhesus 
monkeys exposed to H2S in inhalation chambers67. Much like human case reports, the 
monkeys lost consciousness within 15 min of exposure and had many of the clinical signs of 
human exposure to H2S. Knockdown, gasping of breath, shortage of breath, and death 
occurred during exposure. Following repeated, acute exposures, surviving monkeys lacked 
movement post exposure, but when they did move, they were disorganized and ataxic. The 
brains of surviving monkeys were analyzed for histological changes and exhibited necrotic 
lesions in the cerebrocortex and basal ganglia, specifically in the putamen and caudate 
nucleus.  This study concluded that H2S poisoning can cause brain damage very similar to 
that caused by acute lack of oxygen. Importantly, they were able to recapitulate many of the 
human clinical toxicity 67. 
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While only one study has been conducted with monkeys, most animal studies have 
utilized rodents. The main challenge documented with rodent models of H2S-induced 
neurotoxicity is the difficulty in reproducing brain lesions to recapitulate the human 
condition. A study conducted by Baldelli et al., attempted to produce cerebral necrosis. They 
utilized a common source of H2S, sodium hydrosulfide, because it is stable and much easier 
to work with than H2S gas44. The circulatory and systemic effects of NaSH are identical to 
those produced by H2S68.  Rats were injected with NaSH intraperitoneally to simulate single, 
high exposure to H2S. This study was characterized by high mortality, and only 25% of the 
unventilated rats injected with 120 mg/kg NaSH exhibited necrosis in the brain68. Among the 
ventilated rats, only one rat that survived exhibited cerebrocortex necrosis. The investigators 
concluded that pulmonary edema and hypotension were contributing factors to the 
pathogenesis of neuronal necrosis68.  
A more recent study conducted by Sonobe et al. also injected rats with NaSH was 
characterized by high mortality, only 4 out of 12 rats survived injections69. The investigators 
injected rats once with NaSH, which produced a coma in about 30% of the rats; they 
continued to inject the animals up to two more times.  Two rats that exhibited persistent 
motor deficits had extensive neuronal necrosis in the cerebral cortex with more variable 
lesions in the thalamus, amygdala and the caudate putamen69. This study also reiterates the 
challenge of producing neuronal lesions in rodent models of H2S-poisoning.  
In order to develop effective countermeasures against H2S-induced neurotoxicity, it is 
important to develop animal models that recapitulate the human conditions. This includes 
exposure route, clinical signs, and pathology of the H2S exposure. A significant effort in this 
thesis was directed at developing an ideal mouse model to recapitulate the human condition.  
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Current Treatments for H2S-induced toxicity 
 There is no suitable antidote for treatment of acute H2S toxicity. Developing an 
antidote that can be administered for treatment of mass civilian exposure to H2S is 
particularly necessary. Challenges in developing these treatments include the knowledge gap 
of the pathologic mechanisms underlying H2S induced neurotoxicity, lack of an animal 
model that recapitulates the toxicity observed in humans, the variability in toxic outcomes of 
victims of H2S poisoning, and a steep dose-response curve resulting in a narrow range 
between no effect and toxic concentrations. Furthermore, H2S disassociates rapidly 
systemically and can produce downstream effects quickly, causing an additional challenge of 
developing an antidote that will prevent these changes from occurring.  
 First, the immediate treatment is to remove the victim from exposure to H2S as soon 
as possible, while ensuring rescuers and first responders are properly protected32. 
Decontamination protocols are followed as H2S poisoning victims can be continually 
exposed if H2S is on their skin and clothes70. Once the victim has been removed from H2S 
exposure, respiratory support is essential; they are provided with 100% oxygen therapy to 
focus on airway oxygenation4.  
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Because of some similarities in mechanisms between hydrogen sulfide and cyanide 
toxicity, treatments used in cyanide poisoning have been advocated. Therapeutic goals are to 
inhibit H2S binding to cytochrome c oxidase enzyme, 
much like cyanide, although there are different 
downstream biochemical effects of this binding from 
each chemical. Because of this, treatment with nitrites 
(sodium or amyl nitrite) has been used antidote for H2S 
intoxication (Figure 3)71-73. In a hospital setting, 3% 
sodium nitrite treatment is administered intravenously; 
this induces the production of methemoglobinemia, 
creating sulfmethemoglobin, which has a greater 
affinity for H2S than cytochrome c oxidase but is less 
toxic, thus freeing cytochrome c oxidase allowing 
cellular respiration to resume48, 70, 71, 74. This detoxifies 
H2S in the blood as well.  
Using nitrite has its disadvantages; further studies with nitrite have shown nitrite to be 
ineffective if given more than a few minutes post H2S exposure, and sometimes even slow 
detoxification thereafter43. Given that nitrite needs to be given immediately after exposure, 
this might not be practically feasible as the route of administration (intravenous) requires 
medical expertise. If nitrites are given too aggressively, they can complicate and compound 
the toxicity of H2S by contributing to hypotension4, 42. Nitrite treatment can also cause 
vomiting, headaches, and excessive methemoglobin formation75.  
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Another common treatment for H2S intoxication, sometimes used in conjunction with 
nitrite therapy, is hyperbaric oxygen therapy76. This involves breathing pure oxygen in a 
pressurized setting; the air pressure is increased to three times higher than normal air 
pressure. Under these conditions, lungs and other peripheral tissues are able to receive more 
oxygen than pure oxygen at regular pressure77. Oxygen is also able to detoxify H2S by 
oxidizing sulfide to sulfate and thiosulfate76, 78. Along with any direct effects on H2S toxicity, 
hyperbaric oxygen therapy also prompts vasoconstriction, inhibits an inflammatory response, 
increase nerve cell regeneration, and reduces cerebral edema79, 80.  
As with nitrite treatment for H2S 
poisoning, there are disadvantages to 
hyperbaric oxygen therapy. Hyperbaric 
oxygen therapy needs to be administered in 
chambers or specialized room (Figure 4) 
requiring the victim to be transported to an 
emergency setting where this equipment is 
available. Toxicity associated with hyperbaric 
oxygen therapy have also been reported; patients can experience barotrauma due to the 
increased air pressure, oxygen toxicity, and general risk of transferring an unstable patient to 
the hyperbaric oxygen therapy chamber75.  
Normally, treatment in a hospital setting can involve both hyperbaric oxygen therapy 
administered with nitrite injection. Laboratory studies have found co-administration of these 
therapies are far more successful combined than either given alone81. Other antioxidants that 
generate methemoglobin that have been used include 4-dimethylaminophenolm and 
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thiosufate, and can be used with combination hyperbaric oxygen therapy. Unfortunately, 
these treatment modalities require hospital based settings and cannot be used in the field for 
treatment of mass civilian casualties following acute H2S exposure.  
In the more recent years, an emerging antidote for cyanide and H2S poisoning is 
vitamin B12 and analogs. Cobalt compounds, such as hydroxocobalamin can combine with 
free H2S and catalyze its oxidation during H2S exposure82. Hydroxocobalamin is an FDA 
approved antidote for treatment of cyanide poisoning82 and has  to be administered 
intravenously due to the large volume required to treat cyanide poisoning. In experimental 
settings, hydroxocobalamin has been shown to reduce concentrations of soluble H2S to 
almost zero during infusion of severe levels of H2S83. Alternatively, hydroxocobalamin also 
can exert anti-nitric oxide effects which could counteract some of the H2S toxicity. One case 
report describes the use of hydroxocobalamin in a patient who committed suicide by 
combining household commercial products84. The patient was given hydroxocobalamin upon 
arrival to the hospital. Importantly, thiosulfate and sulfate levels were measured before and 
after administration of hydroxocobalamin. The results showed hydroxocobalamin reduced 
serum sulfide and thiosulfate concentrations indicating hydroxocobalamin might be effective 
in treating H2S intoxication84. There are no studies evaluating and characterizing 
hydroxocobalamin for treatment of H2S poisoning in clinically relevant large animal models. 
Other vitamin B12 analogs are being investigated for treatment for H2S-induced 
neurotoxicity, specifically Cobinamide, a precursor to Cobalamin, will be discussed in 
further detail below.  
The treatments described above are recommended to be given within 5-15 minutes of 
H2S exposure85. Given that these need to be given intravenously, starting an intravenous line 
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can take several minutes, making that window even narrower. Currently, there is no antidote 
for treatment of H2S intoxication that can be utilized in the field in case of a mass civilian 
exposure, such as in the case of a catastrophic industrial accident or following terrorism. An 
antidote that can be given quickly and efficiently is much needed, preferably administered 
intramuscularly from a pre-filled syringe, or intranasal administration. This requires the 
antidote to be potent, administered in small volume, and rapidly absorbed post intramuscular 
injection and can be stored long term.  
Potential Therapeutics 
Binding Agents 
 Drugs that directly bind H2S to enhance its excretion before it can exert its toxic 
effects may be helpful but this has been proven to be challenging as H2S disassociates rapidly 
in vivo. The challenge with current binding agents is that they need to be administered during 
exposure or immediately after.  
 Cobinamide is the precursor to hydroxocobalamin and is currently being investigated 
as a cyanide antidote as well. Cobinamide is water-soluble and can be rapidly absorbed 
following intramuscular injection, making it ideal for intramuscular emergency injections in 
the field. It has been shown that cobinamide is a better H2S antidote compared to 
hydroxocobalamin85, 86. Given that it has a high affinity for the sulfide and it readily reacts 
with sulfide, cobinamide is able to bind 2 moles of sulfide and excrete it from the circulatory 
system to prevent further poisoning by H2S44, 85.  
 While cobinamide has been more extensively studied as treatment for cyanide 
poisoning, recent studies have been investigating cobinamide for treatment of H2S-induced 
toxicity in vitro and in vivo. A study conducted by Jiang et al. investigated in vitro 
mechanisms of H2S toxicity. In many cell types, Jiang et al. observed H2S inhibited 
20 
	  
cytochrome c oxidase activity and induced apoptosis. More importantly, cobinamide reversed 
the cellular toxicity of sulfide. In a lethality study, cobinamide rescued Drosophila 
melanogaster and mice from lethal exposures of H2S. Limitations of this study include the 
route of administration, cobinamide was injected intraperitoneally, and the mice were 
anesthetized during exposure to H2S, not allowing for assessment of clinical signs of toxicity 
during exposure. 
 A second study conducted by Bebarta et al., investigated the efficacy of cobinamide 
compared to hydroxocobalamin for treatment of H2S toxicity in swine. This study 
administered lethal concentrations of H2S via NaSH infusion, and injected the swine 1 min 
post exposure. While all of the cobinamide infused swine survived, none of the swine that 
received hydroxocobalamin and saline infusions survived. Cobinamide also prevented vital 
signs and arterial blood gases from deteriorating.  The objective of the study was to show 
efficacy of cobinamide over hydroxocobalamin, but this does not address the use of 
cobinamide as an agent for mass civilian exposure; NaSH was used by infusion. This is a 
problem as this route of H2S exposure does not recapitulate real life exposure scenarios.  
Based on both these studies, further work needs to be done to evaluate cobinamide in 
a well characterized model of H2S induced toxicity. Not only do we need to investigate if 
cobinamide prevents H2S-induced lethality, but also if the compound can prevent clinical 
toxicity and reduce neurological sequelae that occur in human intoxication cases.  
  Anti-convulsants 
Acute exposure to high levels of H2S have been implicated in the pathology of 
seizure-like events, glutamate and GABA transmission, and involved in glutamate 
excitotoxicity 59, 87, 88. Preventing seizure activity and associated neurological sequelae is a 
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potential therapeutic strategy of  H2S intoxication. Our studies have indicated that the 
severity of seizure activity is correlated to mortality; anticonvulsants, a group of drugs used 
to treat epilepsy, could be potentially be used to treat this.  
Common anti-convulsants include diazepam and midazolam, but midazolam is 
currently considered to be superior to diazepam in efficacy. Midazolam is a common 
benzodiazepine used for its powerful anxiolytic, sedative, anticonvulsant, and amnestic 
properties. Due to its short half-life and rapid onset, midazolam is being recommended as a 
drug of choice in anticonvulsant 
kits 89.  It has been approved for 
prehospital treatment of 
epileptics, and is listed as an 
essential medication according to 
the World Health Organization 90. 
Midazolam is very water soluble, 
causing it to have better injection 
site tolerance and more readily 
absorbed 89. The dual chemical structure of midazolam allows it to have different 
configurations based on the pH of the solution (Figure 5), allowing it be absorbed and to 
enter the brain rather easily.  Maximum plasma concentration is reached in about 30 minutes 
post injection with 90% bioavailability 89, 91. The shelf life of midazolam is also much longer; 
it can be stored for about 36 months at room temperature.  Midazolam is currently being 
considered to replace diazepam as an anticonvulsant for nerve agent exposure 89.  
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 Midazolam exerts its anticonvulsant effects by allosterically potentiating GABAA 
receptors in the synapse 89, 92. It does not activate GABAA directly, but allosterically 
modulates the effects of GABA, the primary inhibitory neurochemical in the brain. 
Midazolam binds to the gamma containing receptors which leads to allosteric potentiation of 
GABA gated hyperpolarization of the cell, inhibiting excitability 89.  
Midazolam has also been used for critically ill patients suffering from pathologic 
effects of oxidative stress such as infection, hemodynamic instability, and hypoxia 93. There 
is evidence supporting the inverse correlation between midazolam and ROS. Midazolam has 
been shown to interfere with the synthesis and release of NO and TNF-alpha 93. Midazolam 
also exerts protective effects during oxidative stress through the activation of Akt via 
phosphorylation in neuronal cells. Akt phosphorylation plays an important role in cell 
proliferation and cell survival 93, 94.  
 Given that midazolam possesses anti-seizure activity and inhibits the effects of ROS, 
midazolam could exert efficacy by interfering with the seizure activity induced by H2S and 
by protecting the cells from ROS produced by H2S intoxication.  
Inflammation and H2S-induced injury 
	   Neuroinflammation is now recognized as a significant contributor to 
neurodegeneration95. It is generally known that microglial and astroglial activation, secretion 
of pro-inflammatory cytokines and nitric oxide production have all been implicated in 
hypoxia-related injury, as is present following H2S exposure.  About 10% of the brains’ glia 
are microglia which typically display a ramified morphology in their resting state. Microglia 
remove debris and toxins, help to establish synapses during development, and produce 
trophic factors 96, 97. Upon stimulation by antigens, mis-folded proteins, or interleukins, 
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microglia can become activated. In the activated state, microglia morphology changes to a 
larger cell body with shorter, thickened processes 98, 99. These classically activated microglia 
are referred to as having an amoeboid shape and are known to secrete pro-inflammatory 
factors. Another activation phenotype deemed ‘alternative’ activation is associated with 
wound healing and repair, where the cells instead produce protective factors such as IL-10 
and arginase 1. Other intermediate stages of microglial activation have also been proposed 
100. Microglia can also become classically activated by neuronal damage in a self-propelling 
process referred to as reactive microgliosis. Astrocytes are the most abundant glia in the 
brain. Astrocytes migrate to the site of injury and develop a hypertrophic morphology during 
neurodegenerative processes 101, 102. These glia, when activated, produce cytokines to set off 
a cascade to mitigate the toxic effects of any insult. When reactive microgliosis occurs, it is 
possible that this process can become detrimental and lead to neurodegeneration. 
 Bebarta et al, found an increase in TNF-α, IL-1β, IL-6 from exposure to NaSH in the 
serum103. It is not known why this increase was observed, whether it was due to hypoxic 
conditions or another mechanism. Hypoxia is known to induce the expression of cytokines 
such as TNF-α, IL-1β, IL-6, and IL-8104, however at low, physiologic conditions H2S has 
been shown to diminish the secretion of pro-inflammatory cytokines105, 106. Further studies 
would need to be done to evaluate the role of H2S on neuroinflammation and whether 
persistent neuroinflammation leads to the neurodegeneration observed in H2S intoxication.  
 
 
  
 
24 
	  
 
CHAPTER 2  
  CHARACTERIZING A MOUSE MODEL FOR EVALUATION OF 
COUNTERMEASURES AGAINST HYDROGEN SULFIDE-INDUCED 
NEUROTOXICITY AND NEUROLOGICAL SEQUELAE 
A manuscript published in Annals of New York Academy of Sciences, 2017 May 31 
 
 
Poojya Anantharama, Elizabeth M. Whitleyb, Belinda Mahamaa, Dong-Suk Kima, Paula M. 
Imermana, Dahai Shaoa, Monica R. Langleyc, Arthi Kanthasamyc, Wilson K. Rumbeiha*,a 
 
a Department of Veterinary Diagnostic and Animal Production Medicine, Iowa State 
University, Ames, IA, United States 
b Pathogenesis LLC, Gainesville, FL 
c Department of Biomedical Sciences, Iowa State University, Ames, IA  
* Corresponding Author at: Department of Veterinary Diagnostic and Animal Production 
Medicine, Iowa State University, 1800 Christensen Dr. Ames, IA 50010 
E-mail address: rumbeiha@iastate.edu (W.K. Rumbeiha) 
 
 
 
 
 
25 
	  
Abstract 
Hydrogen sulfide (H2S) is a highly neurotoxic gas. It is the second most common cause of 
gas-induced deaths. Besides mortality; surviving victims of acute exposure may suffer long-
term neurological sequelae. There is a need to develop countermeasures against H2S 
poisoning. However, no translational animal model of H2S-induced neurological sequelae 
exists. We hereby describe a novel mouse model of H2S-induced neurotoxicity for 
translational research.  Paradigm I: C57/BL6 mice were exposed to 765 ppm H2S for 40 min 
on day 1, followed by 15 min daily exposures for periods ranging from 1 to 6 days. Paradigm 
II: mice were exposed once to 1000 ppm H2S for 60 mins. Mice were assessed for 
behavioral, neurochemical, biochemical, and histopathological changes. H2S intoxication 
caused seizures, dyspnea, respiratory depression, knockdowns, and death.  H2S-exposed mice 
showed significant impairment in locomotor and coordinated motor movement activity 
compared to the controls. Histopathology revealed neurodegenerative lesions in the 
collicular, thalamic, and cortical brain regions. H2S significantly increased dopamine and 
serotonin concentration in several brain regions and caused time-dependent decrease in 
GABA and glutamate concentrations. Further, H2S significantly suppressed cytochrome c 
oxidase activity and caused significant loss in body weight. Overall, male mice were more 
sensitive than females. This novel translational mouse model of H2S-induced neurotoxicity is 
reliable, reproducible, and recapitulates acute H2S poisoning in humans. 
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Abbreviations 
TIC, toxic industrial compounds; IC, Inferior colliculus; GABA, gamma-aminobutyric acid; 
DA, dopamine; DOPAC, 3,4 3,4-Dihydroxyphenylacetic acid; HVA, homovanillic acid; NE, 
norepinephrine;5-HT,serotonin; 5-HIAA, 5-hydroxyindoleacetic acid; 4-HNE, 4-
hydroxynonenol; Iba-1, inducible calcium binding adapter molecule 1; GFAP, glial fibrillary 
acidic protein; NeuN, Hexaribonucleotide Binding Protein-3; Glu-d5, L-glutamic-2,3,3,4,4-
d5 acid; 4-aminobutyric-2,2,3,3,4,4-d6 acid-GABA-d6; PFA, paraformaldehyde; SDS, 
sodium dodecyl sulfate; PBS, phosphate buffered saline; TBS, tris-buffered saline; EDTA, 
ethylenediaminetetraacetic acid; NaCl, sodium chloride; EGTA, Ethylene glycol-bis (2-
aminoethylether)-N,N,N′,N′-tetraacetic acid; NaF, sodium fluoride; Na3VO4, sodium 
orthovanadate; Na4P2O7, sodium pyrophosphate tetrabasic; HClO4, perchloric acid; DAB, 
diaminobenzidine; COS, Carbonyl Sulfide; NaSH, Sodium Hydrosulfide.  
Introduction 
Hydrogen sulfide (H2S) is typical of compounds which are beneficial at normal 
physiological concentrations, but toxic at high doses. Endogenously produced H2S functions 
as a signaling molecule in the brain1, 2. However, H2S in high acute dose exposures is a 
severely toxic xenobiotic3, 4. H2S is a by-product of many industries, including the oil and gas 
industry, intensive animal farming operations, sewer and waste treatment plants, and is 
present in gas storage facilities5-8. It is also used as a raw material for several industrial 
applications8. It is classified as a highly toxic industrial compound (TIC) and is a second 
leading cause of gas-induced death after carbon monoxide9, 10. H2S is a colorless gas and has 
a distinctive rotten egg odor. It is sometimes referred to as sewer gas. It is heavier than air, 
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and therefore collects in low lying enclosed spaces such as manholes, sewer lines, and 
manure pits where it is a hazard11, 12. It can be made easily and inexpensively at home from 
raw materials commonly found in local stores. For this reason, it is increasingly being used 
as suicidal agent13, 14. H2S was used in World War I as a chemical weapon15. For this reason, 
there is significant concern by the Department of Homeland Security about its potential 
misuse as a weapon of mass destruction, particularly in confined spaces such as underground 
transit facilities16. Mass civilian exposure to H2S can also happen if  terrorists target H2S 
storage facilities, or industrial plants producing or using this gas in or near highly populated 
areas17. Industrial plant accidents can also lead to mass civilian population exposures and 
deaths, as occurred in the Poza Rica Mexico recycling18 or in sour gas well blow outs, as 
occurred in Kaixian district in China which resulted in 243 civilian deaths19. 
 Acute toxicity and lingering long-term consequences of acute H2S exposure in 
humans have been reported for many years5, 20, 21-25. Acute exposure to high levels of H2S 
have been reported to cause acute neurotoxic, cardiovascular, and respiratory effects, as well 
as long-term neurological sequelae, including neurodegeneration, memory and motor 
impairment, neuropsychiatric disturbances, moribund state, and even death6, 12, 22-25. It is a 
systemic toxicant, but the central nervous system, respiratory, and cardiovascular systems are 
most sensitive6, 26. Clinical signs of acute H2S intoxication include convulsions, respiratory 
distress, and acute death6, 26, 27. H2S is also known as the “knockdown” gas. A few breaths at 
a high concentration can cause immediate collapse without warning24.  Some survivors of 
acute H2S exposure suffer lingering neurotoxic effects, including movement disorders, 
persistent headache, seizures, neurobehavioral and cognitive deficits, blindness, hearing 
impairment, and sometimes, permanent vegetative states6, 12, 22, 23, 25, 28, 29. The toxic 
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mechanisms of H2S poisoning are not well known. However, ischemia-hypoxia, cytochrome 
c oxidase enzyme inhibition, changes in brain amino acid profiles, changes in 
neurotransmitters, and oxidative stress have been proposed as some of the neurotoxic 
mechanisms30, 31. Regardless of the trigger of H2S-induced neurotoxicity, the downstream 
cellular molecular mechanisms leading to neurodegeneration are yet to be defined6, 23, 32.  
Currently, there is no antidote for treatment of H2S poisoning, particularly for field 
treatment of mass civilian casualties in the event of terrorism or industrial accidents.  Our lab 
is interested in treatment of acute neurotoxicity and neurological sequelae of H2S-induced 
poisoning. The objective of this study was to develop a novel translational mouse model of 
H2S neurotoxicity to recapitulate human inhalation exposure and subsequent health effects. 
This model will be used to study H2S-induced neurotoxic mechanisms and as a benchmark to 
evaluate the efficacy of potential countermeasures for treatment of acute H2S poisoning. 
Prior to commencement of this study, an extensive review of the literature revealed that 
existing animal models do not faithfully recapitulate the human exposure routes and or/focus 
on modeling H2S-induced mortality. For example, the Jiang et al. mouse model used 
anesthetized mice in their H2S inhalation exposure model33. In rat models, rats were injected 
with sodium hydrosulfide (NaHS) intraperitoneally, which does not faithfully reflect the 
common route of exposure in humans, which is inhalation34, 35. Other mouse models of 
inhalation exposure only reported metabolic effects and did not report behavioral changes or 
neurodegeneration36, 37. Our mouse model is unique because it is comprehensive, uses freely 
moving mice exposed to H2S by whole body inhalation exposure, recapitulating the typical 
human exposure route. Most importantly, this mouse model reproduced significant 
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neurological lesions in different parts of the brain and allows evaluation of drug candidates 
easily.  
Materials and Methods 
Chemicals and Reagents 
Methanol (HPLC grade), acetonitrile (HPLC grade), MD-TM mobile phase, sodium dodecyl 
sulfate (SDS), Tris-Cl, phosphate buffered saline (PBS), Alexa Fluor 680 goat anti-mouse 
secondary antibody,  and formic acid were obtained from Thermo Fisher Scientific 
(Waltham, MA). (D- and L-) Glutamic acid, γ-aminobutyric acid (GABA), dopamine (DA), 
3,4 dihydroxyphenlyacetic acid (DOPAC), homovanillic acid (HVA), norepinephrine (NE), 
5-hydroxtryptaamine (5-HT), 5-hydroxyindoleacetic acid (5-HIAA), paraformaldehyde 
(PFA), ethylenediaminetetraacetic acid (EDTA), Triton X-100, Sodium Chloride (NaCl), 
Ethylene glycol-bis (2-aminoethylether)-N,N,N′,N′-tetraacetic acid (EGTA), Sodium 
Fluoride (NaF), Sodium orthovanadate (Na3VO4), Sodium pyrophosphate tetrabasic 
(Na4P2O7), sodium deoxycholate, and 60% perchloric acid (HClO4) were purchased from 
Sigma Aldrich (St Louis, MO). L-glutamic-2,3,3,4,4-d5 acid (Glu-d5) and 4-aminobutyric-
2,2,3,3,4,4-d6 acid (GABA-d6) were purchased from C/D/N Isotopes (Pointe-Claire, Quebec, 
Canada). IRDye 800 donkey anti-rabbit secondary antibody was purchased from Rockland 
Antibodies and Assays (Limerick, PA) Li-COR Blocking buffer was purchased from LI-
COR (Lincoln, Nebraska). Tris- buffered saline (TBS) and Tween-20 were purchased from 
Bio-Rad Laboratories (Hercules, CA) Fluoro Jade C was purchased from Histo-Chem, Inc. 
(Jefferson, AR). Vectastain Elite ABC HRP kit and diaminobenzidine (DAB) was purchased 
from Vectastain Laboratories (Burlingame, CA).  NeuN, Iba-1, and GFAP antibody was 
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purchased from Abcam (Cambridge, UK). Aqueous solutions were prepared using 18.2 
MΩ·cm water (Aries Filter work, Berlin Township, NJ). 
Animals 
All animal studies were approved by the Iowa State University Institutional Animal Care and 
Use Committee. The 7-8 week old C57/BL6 mice used in these studies were purchased from 
The Jackson Laboratories (Bar Harbor, ME). In Paradigm I experiments both male and 
female mice were included in the experiment. In Paradigm II experiments only male mice 
were used. All mice  weighed 20-25g at the beginning of the experiment. Mice were housed 
5 per cage, for each sex, in the Laboratory Animal Resource Facility of the Iowa State 
University College of Veterinary Medicine (ISU CVM, Ames, IA).  They were housed at a 
room temperature of 68-70°F, relative humidity of 35-50%, and a 12-hr light/dark cycle, and 
were provided 14% Protein Rodent maintenance diet (Teklad HSD Inc., WI, USA) and 
drinking water ad libitum. Mice were acclimated for 1 week prior to the start of the studies. 
 H2S Inhalation Exposure 
Fully conscious and freely moving mice were placed in a whole body exposure chamber (Fig 
1A). The chamber is designed to hold up to 10 mice at a time. Hydrogen sulfide is a highly 
toxic gas and all experiments were conducted under a chemical fume hood certified by the 
Environmental Health & Safety at ISU. Gas access to the chamber was from two lines; one 
for breathing air tank under pressure, and the other from a tank containing H2S under 
pressure. The two lines connect to a control panel that allowed separate regulation of 
breathing air and gas in flow (liters/min).  Breathing air was introduced first, followed by 
H2S 2 min later. The concentration of H2S in the exposure chamber was constantly monitored 
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using a H2S monitor (Environmental Equipment and Supply, Harrisburg, PA) that was 
custom designed to measure concentrations of up to 1000 ppm of H2S. 
Exposure Paradigm I 
The exposure Paradigm I is summarized in Fig.1B.  Mice were exposed to H2S by inhalation 
either once or they received 2-7 short additional acute exposures.  On the first day of H2S 
exposure, mice in groups of 10 were exposed to 765 ppm H2S for 40 min. On subsequent 
days, groups of mice were exposed to 765 ppm H2S for 15 min, each day. Following each 
exposure, the chamber was flushed out with breathing air for 2 mins before mice could be 
safely removed.  Separate groups of mice were euthanized after 1, 3, or 7 exposures, 2-10 
min following removal from the H2S exposure chamber.  Mice in the negative control 
breathing air group were exposed following a similar paradigm but were euthanized after the 
7th exposure. This experimental approach allowed progressive evaluation of clinical signs, 
behavioral deficits, and histological lesions in brains of mice following a single or repeated 
short-term exposure to H2S over a 1 week period.  
Clinical Assessment 
         To obtain baseline data, animals were clinically evaluated and weighed starting 3 
days prior to H2S exposure. Mice were weighed daily until euthanasia. Toxicity signs 
monitored during H2S exposure were a modification of the McDaniel and Moser functional 
observational battery38. Adopted endpoints included dyspnea, seizure activity, and latency to 
seizure activity. Knockdown, a clinical effect of H2S poisoning, in mice presented as lateral 
recumbency following seizure activity was an endpoint that we added. The time latency to 
knockdown and number of mice in knockdown were recorded. Mice were evaluated for these 
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clinical signs during exposure in the chamber and again 2 hrs post-exposure. For post-
exposure assessment, mice were removed from their home cages and placed individually in 
an empty chamber for 2 min to assess gait, posture, tremors or convulsions. The same trained 
observer assessed the mice throughout the entirety of the experiment. 
Behavior Testing 
Behavior assessments for open field activity were performed 3 hrs after mice were 
exposed to H2S. This was performed after 2, 4, or 6 H2S exposures using a protocol adapted 
from Gosh et al 39 Briefly, an automated computer-controlled device (Model RXYZCM-16; 
Accuscan, Columbus, OH, USA) was used to measure the spontaneous activity of mice in 
this open field test. The dimensions of the activity chamber were 40 × 40 × 30.5 cm, made of 
clear Plexiglas and covered with a Plexiglas lid with holes for ventilation. Data was collected 
and analyzed by a VersaMax Analyzer (Model CDA-8; AccuScan). Mice were acclimated to 
the chamber two days before H2S exposure. On test days, mice were placed inside the 
infrared monitor for 2 min to acclimate to the chamber. Open field activities were recorded 
for 10-minute test sessions assessing multiple parameters including vertical activity, 
horizontal activity, and distance traveled. To test for coordination and balance, mice were 
subjected to the AccuRotor 4-Channel RotaRod test (rod diameter = 30 mm, height= 38 cm).  
Mice were also trained on the rotating rod for two consecutive days prior to H2S exposure at 
24 rpm for 20 min. Following H2S exposure, mice were given 5 trials for 20 min at 24 rpm 
on test days post H2S exposure.  
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Thiosulfate analysis 
Thiosulfate is a good biomarker of H2S exposure. Blood was allowed to clot at room 
temperature for 15 min, and then spun down at 2,900 x g for 10 min. The serum was 
analyzed for thiosulfate concentration according to Togawa et al40.  Briefly, a 50 µl serum 
sample was added to a 7 dram glass vial, along with 50 µl water and 100 µl 5mM 
monobromobimane.  This was vortexed and incubated for 1 h at room temperature in the 
dark.  A standard curve was prepared by adding using 100 µl water and 100 µl  5mM 
monobromobimane as a blank along with 3 standards of 55, 110, 220 ng of thiosulfate 
adjusting with water to a volume 100 µl.  A 100 µl volume of 5 mM monobromobimane was 
added to all.  After 1 hr, 100 µl of stopping reagent 0.05M KCl-HCl (pH 2.0) was added to 
all samples.  All samples were analyzed by HPLC with fluorescence detection. The mobile 
phase consisted of 25 mM sodium perchlorate (pH 3.0) with acetic acid:acetonitrile, 70:30, 
V:V, with a flow rate of 1 mL/min on a Waters separation module 2695 HPLC system. A 
waters 2475 fluorescent detector was used with an Ex-396 nm and Em-476 nm. The 
thiosulfate was separated on a Dionex WAX-1 150 x 4.6 mm column; retention time was 
approximately 15 min.  
Histopathology and Immunohistochemistry 
Mice were euthanized 24 hrs after the last H2S exposure. First, mice were 
anesthetized deeply with a cocktail of 100 mg/kg body weight ketamine and 10 mg/kg body 
weight xylazine given IM. Once in a surgical plane of anesthesia, the thoracic cavity was 
surgically opened to expose the heart. Fresh 4% paraformaldehyde solution (PFA, pH 7.4) 
was then injected through the left ventricle to perfuse the animal. After perfusion, brains 
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were post-fixed in 4% PFA for 24 hrs, paraffin embedded, sectioned at 5 microns, and 
stained with hematoxylin and eosin for routine histopathology. Additional brain sections 
were stained using fluoro jade C or stained using an indirect immunostaining protocol that 
employed primary antibodies directed against NeuN, GFAP, Iba-1 , or 4-HNE. 
Diaminobenzidine was the chromogen used. Stained sections were examined microscopically 
using a Nikon Eclipse Ci-L microscope with DS-Fi2 camera or EVOS FL fluorescence 
microscope. Routine histopathology, as well as immunohistopathology, was conducted by a 
board-certified pathologist blinded to the study design. The semi-quantitative scale used for 
scoring the severity of lesions is summarized in Supplemental Table 1.  
Cytochrome c oxidase enzyme activity 
Mice for all biochemical assays were euthanized by decapitation. Brains were immediately 
removed from the skull and micro dissected into different brain regions on ice. Brain tissue 
samples were stored at -80 °C until analysis. Cytochrome c oxidase enzyme was extracted 
from micro-dissected brain regions and enzyme activity determined using an assay kit 
(ab109909) from Abcam (Cambridge, MA, USA) according to manufacturer’s protocol.   
Neurochemical analysis 
Monoamines 
To determine H2S-induced neurochemical changes, different brain regions were 
analyzed for changes in dopamine (DA) and its metabolites, 3,4-Dihydroxyphenylacetic acid 
(DOPAC) and homovanillic acid (HVA). Samples from these brain regions were also 
analyzed for serotonin (5-HT), its metabolite, 5-hydroxyindoleacetic acid (5-HIAA) as well 
as norepinephrine (NE). Samples were prepared and quantified as described previously41. 
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Briefly, neurotransmitters were extracted from different brain regions in 0.2 M perchloric 
acid solution containing 0.05% Na2EDTA, 0.1% Na2S2O5, and isoproterenol (internal 
standard).  
DA, 5-HT, NE, and their respective metabolites were separated isocratically by a 
reverse-phase column with a flow rate of 0.6 ml/min mobile phase (10% acetonitrile, 1% 
sodium phosphate, 89% water) using a Dionex Ultimate 3000 HPLC system (pump ISO-
3100SD, Thermo Scientific, Bannockburn, IL) equipped with a refrigerated automatic 
sampler (model WPS-3000TSL). The electrochemical detection system included a CoulArray 
model 5600A coupled with an analytical cell (microdialysis cell 5014B) and a guard cell 
(model 5020). Data acquisition and analysis were performed using Chromeleon 7 and ESA 
Coularray 3.10 HPLC Software. 
GABA/Glutamate 
Micro-dissected mouse brain tissues were weighed and transferred to 1.5 mL 
Eppendorf tubes. All samples were spiked with 10 µl Glu-d5 (1400 µg/mL) and GABA-d6 
(780 µg/ml) as internal standards and mixed thoroughly. This procedure was performed on 
ice. Subsequently, samples were extracted with 900 µl Methanol/water 85/15 (v/v) 42 and 
vortex-mixed for 5 min at 2500 rpm on a multi-tube vortexer for thorough mixing. The 
mixtures were then filtered through 0.45 µm filter discs and subject to LC-MS/MS analysis. 
GABA and glutamate levels were measured by LC-MS/MS analysis on a Quattro 
Premier XE triple quadruple mass spectrometer (Milford, MA), equipped with a Waters 
e2695 HPLC separation module. The separation of GABA and glutamic acid was performed 
by a reversed phase C18 HPLC column (Luna, 150×4.6 mm, 5 µm) obtained from 
36 
	  
Phenomenex (Torrance, CA). The mobile phase consisted of 0.1% formic acid   aqueous 
solution (A) and acetonitrile (B). The analysis was performed using an isocratic elution of 
75%:25% mobile phase A:mobile phase B at a rate of 0.6 ml/min. Column temperature was 
30°C, and autosampler temperature was 4°C. Analytes were detected in the positive 
electrospray ionization mode with the capillary voltage of 3.1 kV. The source temperature 
was 350°C. The desolvation gas flow rate was 800 l/hr. the cone gas flow rate was 20 l/hr. 
Data were acquired and analyzed using MassLynx version 4.1 (Waters, Milford, MA).   
Western Blot  
Micro-dissected brain tissues were lysed in modified RIPA lysis buffer (1% Triton X-
100, 1 mM EDTA, 100mM NaCl, 1 mM EGTA, 1 mM NaF, 20 mM Na4P2O7, 2 mM 
Na3VO4, 10% glycerol, 0.1% SDS, 0.5% deoxycholate, 50 mM Tris-HCl, pH 7.4) via 
sonication. Brain homogenates were prepared as described previously43. Protein 
concentration of samples was measured using the Bradford assay. Western blotting was 
performed as described previously 43. Briefly, the samples containing equal amounts of 
proteins were loaded and fractionated in a 10-12% SDS-PAGE gel and transferred onto a 
nitrocellulose membrane. Membranes were blocked with 5% milk in TBS supplemented with 
0.1 % Tween-20 or Li-cor blocking buffer. Primary antibodies against specific proteins were 
incubated with the membrane overnight at 4°C. After rinsing thoroughly in PBS 
supplemented with 0.1% Tween-20, the membrane was incubated with Alexa Fluor 680 goat 
anti-mouse or IRDye 800 donkey anti-rabbit secondary antibodies. For the loading control, β-
actin antibody was used. Immunoblot imaging was performed with an Odyssey Infrared 
Imaging system (LI-COR, Lincoln, NE, USA). ImageJ software (National Institutes of 
Health, Bethesda MD, USA) was used to quantify Western blot bands. 
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 Data Analyses  
Data are presented as mean and standard error of the mean. Biochemical and 
neurochemical endpoints were analyzed using a student’s t-test comparing the H2S exposed 
mice to the breathing air mice. Behavioral data was analyzed using 2-way ANOVA with a 
post-hoc test comparing the H2S groups with the breathing air group. Endpoint data from 
male and female mice were compared using analyses of variance (ANOVA) models, with 
treatment, gender and their interaction and fixed effects. Behavioral data were analyzed using 
repeated measures ANOVA models, with treatment, day, gender and their interactions and 
fixed effects, and mouse as the subject of repeated measures.  Statistical tests were performed 
on Prism 6 (GraphPad Prism Software) or SAS. A p value less than 0.05 was accepted as 
statistically significant.  
Exposure Paradigm II 
Exposure Paradigm II is summarized in Fig 7A. This paradigm reflects the typical 
human exposure scenario of a single acute exposure to high H2S concentrations, followed by 
rescue. This experiment used only male mice because results of previous experiments 
indicated that males are more sensitive to H2S than females. Separate groups of mice were 
exposed either to breathing air or 1000 ppm  
H2S by whole body inhalation for 60 min. Following exposure, the chamber was 
flushed out with breathing air for 2 min before mice were retrieved from the chamber. Mice 
were euthanized 7 days post-H2S exposure for histopathological evaluation of brain lesions 
using the same protocol as in Paradigm I above.  
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Results 
Paradigm I: H2S induced seizures and knockdowns in mice  
        Both male and female mice exposed to H2S showed similar clinical toxic effects.  
The main clinical effects of H2S exposure are summarized in Supplemental Table 2.  Mice 
exposed to H2S exhibited hunched posture, piloerection, and dyspnea during exposure. 
Neurologic effects observed during exposure included tonic-clonic seizures, knockdown, and 
ataxia (Suppl. Table 2). Prior to seizure activity, mice exhibited characteristic running fits 
followed by tonic-clonic seizures with paddling of limbs and urination. Salivation was 
frequently observed in mice in knockdown state. Upon termination of gas exposure, mice 
regained consciousness and activity within 5-10 min. For mice which received more than one 
exposure, a notable observation was that H2S-exposed mice showed increased sensitivity 
with each subsequent exposure. For example, during the first exposure the seizures were not 
observed until after 20 min of H2S exposure, whereas seizures were observed as early 5 mins 
in subsequent exposures (Fig.1C). The average time mice experienced the first seizures and 
knockdown was shorter in males than in females, indicating that males are more sensitive 
than females. In males, the average time at first seizure was 21±6 min while in females it was 
observed at 29±4 min. The first knockdown was observed at 25±9 min in males, compared 
with 27±4 min in females. Cumulative mortality at the end of the study was relatively low; 
15% for male mice and 13% for female mice. H2S also caused a statistically significant loss 
in body weight in both male and female mice, compared with controls. Negative control mice 
exposed to breathing air continued to gain weight during the course of the study (Fig.1D).  
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Evaluation of behavioral deficits caused by H2S exposure was tested by performance 
on the RotaRod and VersaMax open field tests. Mice exposed to H2S had a statistically 
significant reduction in locomotor activity in the open field test based on vertical activity, 
horizontal activity, and total distance traveled compared with negative controls. On the 
RotaRod, mice exposed to H2S fell off the RotaRod at a significantly shorter time compared 
with negative controls.Statistically significant changes were observed on all days of 
behavioral assessment for males including following a single exposure. In female mice, 
however, changes were observed on days 4 and 6, again suggesting higher susceptibility of 
males than females (Fig. 1E).  
Thiosulfate is an oxidation product of H2S and is used as a biomarker of H2S 
exposure 14, 44.  In this model, thiosulfate levels were significantly increased in H2S-
exposed mice in both sexes compared with control mice (Suppl. Fig 1). Our data provides 
further confirmation over the validity of our model to assess H2S-induced neurodegenerative 
changes. Collectively, these results indicate that H2S caused significant motor impairment in 
mice exposed to H2S relative to breathing air negative control, with the males being more 
sensitive than females.   
 H2S-induced lesions in the brain  
H2S exposure induced morphological changes in select brain regions. Brain regions 
affected and the severity of neurological lesions evaluated are summarized in Fig 2.  
Neurodegeneration was observed in different brain regions but especially in the inferior 
colliculus (IC) and the thalamus. Severity of lesion increased with additional exposures and 
varied from activated glial cells and oxidative stress with single or two exposures to frank 
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bilateral or, much less commonly, unilateral, well-circumscribed necrosis in the IC and or 
thalamus on day 7 (Fig 2).  Bilateral neurodegeneration and necrosis of the IC was 
consistently present following 7 days of H2S exposure. This was the first region to be 
affected and lesions were noticeable as early as 3 days after H2S exposure.  The thalamus 
was the second regions most frequently affected after the IC. As in the IC, thalamic lesions 
were also well demarcated from adjacent, non-necrotic tissue.  In both regions, lesions began 
as fine vacuolation of the neuropil, followed by gliosis, and degeneration and necrosis of 
neurons, ultimately with loss of all cellular components. Mild to moderate hemorrhage was 
also frequently observed, especially in the IC region.  Late stage morphological changes were 
characterized by gliosis and Gitter cells phagocytosis of cellular debris, as well as 
proliferation of capillaries in necrotic areas. H2S inhibited cytochrome c oxidase activity in 
mice  
We characterized the effects of H2S in different brain regions over time. Results are 
summarized in Fig 3. H2S statistically significantly inhibited cytochrome c oxidase activity in 
all brain regions examined in this study, compared to negative control mice (p< 0.05). By day 
7, H2S exposure resulted in 70% inhibition of cytochrome c oxidase enzyme activity in the 
IC of both male and female mice, indicating effects of H2S on this enzyme are cumulative. 
There were no statistically significant differences between male and female mice with respect 
to enzyme inhibition by H2S.  Statistically significant inhibition of cytochrome c enzyme 
activity was also observed in the thalamus and in other brain regions where histologic lesions 
were not prominent, such as the cortex (Fig. 3C). 
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H2S induced changes in neurotransmitter levels in various brain regions 
Because of the observed clinical, behavioral and morphologic changes in H2S-exposed mice, 
we measured DA, 5-HT, NE and their metabolites in different brain regions. Results are 
summarized in Table 1. There were statistically significant differences among 
neurotransmitters, which were anatomically location-dependent. Interestingly, DA 
concentration, with a few exceptions, was significantly increased across all brain regions 
examined (Table 1).  These results indicate H2S exposure induced statistically significant 
changes in monoamine neurotransmitter content across brain regions studied, including those 
where neurodegeneration was not manifested (Suppl. Table 3).  
Gamma-aminobutyric acid (GABA) and glutamate play a role in seizure activity, so 
we investigated the effect of H2S on levels of these neurotransmitters.  Results are 
summarized in Fig. 6. In male mice only, H2S caused a significant decrease in GABA and 
glutamate following 3 or 7 exposure compared with breathing air negative control (Fig. 4A-
B). These changes were not found in female mice.  
H2S-induced neuronal loss and oxidative stress 
 Immunohistochemical studies focused on the IC and thalamus.  
Immunohistochemical staining with antibody directed at NeuN, a marker of neurons, 
revealed loss of neurons in these regions (Fig 5A). Immunostaining with Fluoro jade C 
revealed degenerating neurons in the IC of H2S-exposed mice (Fig 5B). Therefore, neuronal 
cell loss in these brain regions is a major effect of H2S-induced neurotoxicity. We also 
examined the level of 4-hydroxynonenol (4-HNE), a by-product of lipid peroxidation, via 
Western blot analysis and immunohistochemistry. Results show that H2S exposure produced 
42 
	  
50% more 4-HNE in the IC on day 7 of H2S exposure compared to control (Fig. 6A). Ionized 
calcium binding adapter molecule 1 (Iba-1), a biomarker of microglial activation, was 
significantly increased by more than 50% on day 3 (Fig. 6B). Expression of GFAP was also 
induced by H2S exposure, reflecting activated astrocytes (Fig. 6C). These results indicate the 
roles of oxidative stress and neuroinflammation in H2S-induced neurotoxicity.  
Exposure Paradigm II 
H2S induced seizures and knockdowns in mice  
A single acute exposure to a higher concentration of H2S at 1000 ppm for 60 minutes 
resulted in mice exhibiting similar clinical signs as in Paradigm I but with high mortality. 
Mice started seizing within 6-9 min of H2S exposure, and manifested knockdown by 10-16 
min of exposure. Seizure activities were similar to those described in Paradigm I. Cumulative 
mortality at the end of the 7 day study was 40%.  
H2S-induced lesions in the brain  
Approximately 40% of surviving mice manifested neurological lesions, compared to 
100% of the mice in Paradigm I (Fig 7B). Control animals had no lesions.  Exposure to a 
single high concentration of H2S also resulted in vacuolar lesions with degeneration and loss 
of neurons and formation of a glial response, similar to those observed in animals in 
Exposure Paradigm I.  Brain regions affected included the IC, thalamus, and additional foci 
of degeneration, necrosis and scarring in the cortex (one of 5 mice) and pons (two of five 
mice) in the single, acute exposure (Fig 7C).  The animal that had a cortical lesion had a 
large, unilateral area of necrosis in the frontal and parietal region with marked vacuolization 
and neuron loss in layer 4 of the cortex, neuronal degeneration and necrosis in more 
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superficial layers, and moderate gliosis and endothelial hypertrophy and hyperplasia in all 
layers of the affected cortical regions.  
Discussion 
The goal of this study was to develop a rodent model of H2S-induced neurotoxicity, 
with a relevant route of human exposure, for characterizing mechanisms of H2S-induced 
neurotoxicity and for use in translational studies aimed at evaluating the efficacy of 
countermeasures against H2S neurotoxicity2. This study has led to the development of a novel 
inhalation mouse model of H2S-induced neurotoxicity and neurodegeneration that 
recapitulates many of the features of the human condition2, including clinical signs, 
behavioral responses, and neurodegeneration 5, 45-48. There have been some recent attempts at 
developing such models, but the routes of H2S exposure employed were irrelevant to 
chemical terrorism or farm/industrial H2S exposure. These animal models also failed to 
express reproducible brain lesions in an appreciable number of test subjects. For example, a 
rat model demonstrated neuronal necrotic lesions in the superficial and middle layers of the 
cerebral cortex and posterior thalamus, but the route of H2S exposure was by intraperitoneal 
(IP) injection of NaHS35. This study was also limited in scope, focusing on histopathological 
and behavioral endpoints, without evaluating neurochemical and biochemical changes. This 
model was characterized by high mortality, with only a small number of rats surviving for 
morphological evaluation of neuropathology. Another excellent study using a similar rat 
model of IP NaHS injection highlighted the difficulty of inducing brain lesions in this 
model34. Only 1 in 3 surviving rats that received a higher dose demonstrated frank lesions 1 
week post exposure34.  In an inhalation mouse model using anesthetized mice, the focus of 
the study was biochemical changes and neurodegeneration was not evaluated33. None of 
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these alternative models examined sex differences in rats or mice.  An additional advantage 
of our mouse model, besides using the appropriate route of exposure in conscious mice, is 
that multiple endpoints were evaluated, and neurotoxicity and neurodegeneration was 
assessed using various exposure paradigms to assess the progression and severity of H2S-
induced toxicity. Besides, gender-specific differences in susceptibility to H2S-induced 
neuropathology were also evaluated, which was lacking in other models. 
The mechanisms underlying acute toxicity and continued neurodegeneration of 
victims of H2S toxicity are not well understood, but cytochrome c oxidase inhibition, ATP 
depletion, and ischemia/hypoxia are often cited as causal to H2S-induced 
neurodegeneration30, 49-51. H2S exposure has been known to cause a wide array of 
neurological clinical effects, including persistent headaches, nausea, lethargy, seizures, 
dizziness, abnormal reflexes, sleeping disorders, hearing impairment, movement disorders, 
and loss of consciousness, sometimes leading to permanent vegetative states21. All mice in 
this study exhibited seizures and the “knockdown” effects during H2S exposure, replicating 
what is commonly reported in humans. Humans have also been reported to have a lower 
threshold to H2S induced neurotoxicity following additional H2S exposure; as was observed 
in this mouse model50. Mice receiving repeated H2S exposure were more vulnerable to H2S 
poisoning. In a pilot dose-range finding study preceding this detailed study, upon a second 
exposure to 765 ppm H2S for 40 min, there was almost 100% mortality; yet on 1st exposure 
only about 5% mortality was observed at the end of a 40 min exposure. The earlier 
manifestations of seizures and knockdown in mice in this study upon subsequent second and 
third exposures, compared to a single naïve exposure further confirms the validity of our 
model and its relevance to human exposure. In a study conducted on  female mice exposed 
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four times to 100 ppm at 4 day intervals, Savalaine et al. reported that biochemical effects of 
repeated H2S exposure are cumulative37. Collectively, these results suggest that the acute 
effects of H2S-induced neurotoxicity manifested in mice in Paradigm I reflect cumulative 
effects of H2S as was observed by Savalaine et al37. Results of this study showed cumulative 
inhibition of cytochrome c oxidase activity, neuro-inflammatory response, and reduced 
GABA and glutamate with repeated short-term exposures. The mechanisms of these 
cumulative effects are beyond the scope of this study and should be the subject of future 
investigations. Cumulative effects are likely one of the factors contributing to enhanced 
sensitivity of mice to subsequent acute H2S exposures.  
 The brain is a primary target organ of H2S intoxication and many victims of acute 
H2S poisoning report persistent neurological problems post-H2S exposure, including 
movement disorders such as spastic gait22, 23, 25, 50. Consistent with this observation, both 
open field test and RotaRod tests revealed impairments in locomotor activity and motor 
coordination in mice exposed to H2S. Interestingly, male mice were more sensitive to these 
motor deficits than females, whereby males displayed these symptoms earlier than females. 
The notion that male mice are more sensitive than female mice is further supported by the 
observation that time to seizure induction was shorter in males than females and that only 
male mice manifested significant inhibition of GABA. The reasons for these qualitative sex 
differences in response to H2S poisoning are currently not clear. Future studies to examine 
the role of hormones in these qualitative differences are recommended.  
It is interesting that H2S induced brain region-specific neurodegeneration and 
necrosis.  Necrosis in the IC and thalamus of H2S-exposed mice suggests these regions to be 
most vulnerable to H2S-induced neurotoxicity. Severe neuronal damage and an intense glial 
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response induced by H2S bears close resemblance to that induced by NaHS and carbonyl 
sulfide (COS) gas, a precursor of H2S35, 52. Unlike NaHS and COS, which cause severe 
cortical necrosis, H2S exposure by inhalation did not result in severe cortical necrosis in this 
mouse model, though the cortex was also affected.  The mechanisms underlying the selective 
sensitivity of the IC and thalamus to H2S-induced neurodegeneration are not clear.  However,  
the IC is a brain region known to receive the highest blood supply and to have a very high 
metabolic rate53. The IC is part of the auditory pathway; it is interesting that hearing 
impairment is a frequently reported lingering effect of H2S intoxication in humans50. The 
thalamus is a key brain region which is at the cross roads of key neural tracts54. 
Neurodegeneration in this region can virtually manifest in many of the clinical signs reported 
in human victims of H2S poisoning, including migraines55. It will be of interest to determine 
the reasons why other regions are not vulnerable to the same extent as the IC and thalamus. 
Considering cytochrome c oxidase enzyme activity was globally affected in the brain, 
inhibition of this enzyme by H2S is unlikely to be the explanation for regional differential 
susceptibilities. Previous studies point to the idea that ischemia-hypoxia could be 
contributing factors to the neurodegeneration induced by H2S30, 34, 36, further studies would 
need to be conducted to elucidate the exact role hypoxia plays in H2S induced 
neurodegeneration.   
  A key observation in this study is that histopathological and immunohistopathologic 
findings were readily reproducible and served as reliable endpoints to assess the severity of 
H2S-induced neurotoxicity in this model. We therefore recommend histopathology and 
immunohistopathology as key endpoints of translational studies evaluating the efficacy of 
medical countermeasures for treatment of H2S-induced neurodegeneration.   
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In human victims of acute H2S exposure lesions are reported in various parts of the 
brain with the cortex, thalamus, and the basal ganglia being regions most commonly 
involved20, 22, 23. Lesions in similar brain regions, including the collicular regions have also 
been reported in animals56. Faithfully reproducing lesions in brains of laboratory animals, 
following a single H2S exposure, has been a challenge34,35,57. This may be a result of 
physiological differences between rodents and nonhuman primates and humans. Baldelli and 
Sonobe using injected NaHS showed that lesions were manifested only in a small number of 
surviving rats. Besides the brain, lungs and the cardiovascular system are other secondary 
target organs of H2S exposure. H2S-induced lung edema in particular may contribute to 
hypoxia and is best replicated in an inhalation model. A good inhalation model of H2S-
induced neurotoxicity was shown in an elegant study in Rhesus monkeys exposed either once 
or at least twice to H2S. Using this primate model, Lund et al. reproduced lesions in  the 
cortex and basal ganglia of monkeys exposed twice to 500 ppm with 3 days in between 
exposures for 25 mins initially and 17 mins on second exposure57. Monkeys that died acutely 
lacked brain lesions. Those with at least 2 exposures that lived at least 3 days post exposure 
developed lesions.  Results of this primate study are consistent with observations in the 
mouse model presented in this study. Although the non-human primate model is attractive 
because it yields lesions in similar brain regions as humans, facilities to support this kind of 
research are not widely available.  
The mouse model reported in the current study followed two exposure paradigms. 
Though exposure Paradigm I is atypical of exposure scenario in humans, it has the advantage 
that it is associated with low mortality, and a high frequency of mice exhibiting brain lesions. 
This exposure paradigm is ideal for assessment of countermeasures against H2S-induced 
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neurodegeneration with minimal numbers of mice to achieve meaningful statistical 
significance. Because the molecular mechanisms leading to cell death are yet to be defined, 
the window of opportunity for efficacy of  such drugs is not known30. From our observations 
in this study, neurodegeneration becomes morphologically manifested at least 3 days post 
H2S-exposure, suggesting a wider intervention time for treatment of neurodegeneration. 
Paradigm II on the other hand, faithfully replicates the typical single human exposure, but it 
is associated with high mortality and is ideal for evaluating efficacy for countermeasures that 
increase survival. In our models, most deaths occurred during H2S exposure, as is reported in 
human case reports of H2S poisoning18, or other rodent models33-35. Therefore, rescue 
countermeasures must to maximize survival must be given during exposure.  . 
Neurochemical alterations in the brain have been correlated with many movement 
disorders 58, 59, specifically lesions in the basal ganglia 60.  In order to understand the origin of 
the motor deficits observed in this mouse model, the striatum was analyzed for monoamine 
neurotransmitter changes after H2S exposure. A single or repeated short term exposures to 
H2S resulted in increased DA concentration (Table 1). This is consistent with the literature 
demonstrating H2S as a monoamine oxidase enzyme inhibitor 61.  Interestingly, mice exposed 
to H2S also had lower norepinephrine levels compared to negative controls (Suppl. Table 3).  
A positive correlation in the levels of the aforementioned neurotransmitters were evidenced 
in the thalamus, cortex and striatum of mice exposed to H2S (Table 1). It is notable that these 
neurochemical changes were observed in brain regions that did not manifest morphological 
lesions, suggesting neurodegeneration may not be an essential prerequisite for the 
manifestation of neurochemical changes. 
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The mechanisms of H2S-induced seizures have not been characterized. However, 
neurotransmitter imbalances can contribute to seizures62,63, and in this study we demonstrated 
significant changes in neurotransmitter levels in the brain.  GABA and glutamate are 
important regulators of inhibitory and excitatory signals in the brain. H2S exposure time-
dependently decreased GABA and glutamate in the inferior colliculus of the brain. 
Dysregulation of glutamate and GABA may partially explain the seizurogenic and neurotoxic 
effects of H2S.  
A consistent hallmark of H2S exposure that is well characterized is the inhibition of 
cytochrome c oxidase (complex IV) of the electron transport chain33,64,65. Our model 
recapitulates this biochemical effect: cytochrome c oxidase activity was significantly 
decreased on all days of H2S exposure in both male and female mice. Specifically, 
cytochrome c oxidase activity was reduced in the inferior colliculus, the thalamus, and 
cortex. This data suggests that inhibition of cytochrome c oxidase may not be the sole cause 
of H2S-induced neurotoxicity and neurodegeneration.  
A biomarker of H2S exposure which has been reported in the literature is an increase 
of thiosulfate14, 44. In this study we also show that H2S exposure increases serum thiosulfate 
levels. It is anticipated that serum thiosulfate concentration will be a valuable biomarker for 
evaluation of efficacy of countermeasures, such as cobinamide, which bind H2S to prevent it 
from interacting with critical sensitive molecules such as cytochrome c oxidase.  
This study also evaluated gender differences in susceptibility to H2S-induced 
neurotoxicity in Paradigm I. Some differences were found, and overall males were found to 
be more sensitive to H2S-induced acute toxicity than females. This is supported by data of 
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body weight loss, average latency time to exhibit seizures and time taken to demonstrate 
knockdown, severity of brain injury, and performance in behavioral tests.  It is for this reason 
that only male mice were used in Paradigm II of the study. The reason(s) for this apparent 
increased susceptibility of male mice to H2S is/are unknown but could be hormonal or 
magnitude of locomotor activity could be a critical determinant. For this reason, we 
recommend using male mice with inclusion of a smaller cohort of female mice in future 
translational efficacy studies evaluating potential drug candidates for treatment of acute and 
lingering effects of H2S-induced neurotoxicity.  
In conclusion, we have developed a mouse model which recapitulates many of the 
hallmarks of H2S-induced neurotoxicity and neurodegeneration using two exposure 
paradigms. In Paradigm I, all animals exposed to H2S had a reduction in body weight, motor 
deficits, and exhibited clinical signs characteristic of H2S poisoning, including seizure 
activity and the “knockdown” response.  Male mice were more sensitive that females, 
determined using multiple endpoints. The animals exposed to H2S also showed a cumulative 
toxicity to H2S, a phenomenon also observed  human beings. These animals also had 
neurochemical imbalances in almost all of the brain regions investigated, which could be a 
contributing factor to seizure activity and persistent neurological sequelae observed in this 
model. Mortality was low in Paradigm I and consistently reproducible necrotic lesions were 
present in brain regions previously shown to be sensitive to H2S toxicity, such as the inferior 
colliculus and the thalamus. We recommend this approach for testing the efficacy of 
countermeasures against neurodegeneration because it uses a small number of mice to 
achieve statistically significant and meaningful results. Paradigm II on the other hand is 
associated with high mortality, with a small percentage of surviving mice manifesting similar 
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lesions in same brain regions, albeit less severe. We recommend this approach for testing the 
efficacy of rescue countermeasures to increase survival rate. There is no perfect animal 
model of the H2S-induced neurotoxicity and neurodegeneration. The mouse model presented 
in this study is novel and for the first time provides a tool for mechanistic and translational 
studies. Currently, no other animal model uses whole body H2S inhalation exposure on fully 
awake animals. A wide variety endpoints to be evaluated in this model have been established, 
including mortality, clinical, biochemical, and neurochemical changes, which parallel those 
observed in H2S toxicity in human beings and will provide metrics suitable for the evaluation 
and screening of antidotes of H2S-induced neurotoxicity.  
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Figure 1.  Whole body inhalation chamber and system used in the present studies (A) 
Treatment Paradigm 1 of H2S induced neurodegeneration in mice (B). Seizures and 
knockdown induced by H2S in male and female mice, n=8-10/ group (C) Weight loss in mice 
exposed to H2S (765 ppm) n=8-10/group (D) Behavior deficits induced by H2S (765 ppm) in 
male and female mice, n=8-10/group (E). *,**p<0.05-0.01 compared to breathing air 
controls of each sex.  
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Figure 2. Vacuolization of the neuropil and neuronal death in the inferior colliculus and 
thalamus of mice brains after 1, 3, and 7 exposures to H 2 S (765 ppm). Severe and 
widespread necrosis and glial response in the IC (arrows) after 7 days of exposure to H 2 S 
(A). Size bars =1000 microns for 10X and 100 microns for 400X. The attached graph 
summarizes changes in histopathology over time. Histopathology score determined from 
semi quantitative grading scheme in Supplemental Table 2 (B) n=5/group. 
*,**,***p&lt;0.05-0.001 compared to breathing air controls. 
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Figure 3. Decrease in cytochrome c oxidase activity in inferior colliculus (A), thalamus (B) 
and cortex (C) of male and female mice following exposure to H2S (765 ppm). n=3-5/group 
*,**,***p<0.05-0.001 compared with breathing air controls. 
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Figure 4. Changes in GABA (A) and glutamate levels (B) in the inferior colliculus of mice 
following exposure to H2S (765 ppm). n=5/group. *,**,***p<0.05-0.001 compared to 
breathing air controls. 
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Figure 5. Loss of neurons (NeuN) in the inferior colliculus and thalamus of mice following 
exposure to H2S (765 ppm) (A). Degenerating neurons, stained with fluoro jade c, (white 
arrows) within a representative inferior colliculus of mice following exposure of H2S, 
n=6/group (B).  
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Figure 6. Oxidative stress in the inferior colliculus of male mice following exposure to H2S ( 
765 ppm). n=3/group. *p<0.05 compared with breathing air controls. 
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Figure 7. Treatment Paradigm II of H2S induced neurodegeneration in mice (A). Prevalence 
of lesions in Paradigm I vs Paradigm II in the inferior colliculus and thalamus (B) 
Vacuolization of the neuropil and neuronal death in the inferior colliculus, thalamus, and 
cortex of mice exposed to H2S (1000 ppm), n=5/group.*30% died in chamber during H2S 
exposure. 100X(C) 
 
 
64 
	  
 
Table 1. Dopamine and metabolite changes in various brain regions of mice following 
exposure to 765 ppm of H2S. n=4-5/group. *,**p<0.05-0.01 compared to breathing air 
controls 
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Supplemental Figure 1. Thiosulfate levels in serum of male and female mice following 
exposure to H2S. n=5/group *,**,***p<0.05-0.001 compared to breathing air controls. 
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Supplemental Table 1. Semi-quantitative grading scheme to assess histological lesions 
caused by H2S in mouse brains.  
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Supplemental Table 2. Summary of functional observation of battery evaluation during H2S 
exposure (765 ppm) of male and female mice, including seizure activity, knockdowns, and 
other clinical signs.  
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Supplemental Table 3. Serotonin, 5-HIAA, and norepinephrine levels in various brain 
regions of mice following exposure to 765 ppm of H2S. n=4-5/group. *,**p<0.05-0.01 
compared to breathing air controls.	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Abstract 
Hydrogen sulfide (H2S) is a highly neurotoxic gas. Acute exposure can lead to death and 
neurological sequelae among survivors. A drug for treating acute H2S intoxication in the field 
is acutely needed. Using a novel mouse model, we evaluated the efficacy of Cobinamide 
(Cob) for this purpose. There were two objectives: 1) to determine the dose-response efficacy 
of Cob; and 2) to determine the effective therapeutic time window of Cob. We exposed mice 
to 765 ppm H2S gas in a sealed chamber. In objective 1, mice were injected intramuscularly 
with Cob at 0, 50 or 100 mg/kg at 2 min post H2S exposure. In objective 2, mice were 
injected intramuscularly with 100 mg/kg Cob at 2, 15, and 30 min post H2S exposure. 
Control mice exposed to breathing air or to H2S alone were injected with 0.9% saline. Cob 
significantly reduced H2S-induced lethality in a dose-dependent manner (p<0.05). Cob-
treated mice exhibited significantly fewer seizures and “knockdowns” compared to the H2S-
exposed group. Cob also reversed H2S-induced weight loss, behavioral deficits, 
neurochemical changes, cytochrome c oxidase enzyme inhibition, and neurodegeneration in a 
dose- and time-dependent manner (p< 0.01). Overall, our findings show that Cob increased 
survival and is neuroprotective against H2S-induced toxicity.  
 
Keywords 
Cobinamide, hydrogen sulfide, neurotoxicity, neurodegeneration, neuroprotection 
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Introduction 
Hydrogen sulfide (H2S) is a highly toxic gas. High, acute exposures lead to severe 
toxic effects, with most deaths occurring at the scene of exposure1. Among toxic gases, H2S 
is the second most common cause of human death after carbon monoxide poisoning2, 3.  Most 
H2S-induced deaths are occupational-related1, 4-6, but suicide in confined spaces is a growing 
cause of death by H2S exposure7, 8. There are many sources of H2S in the environment, 
including occupational settings and natural discharges from volcanic activities and hot 
springs9, 10. Hydrogen sulfide is a contaminant of oil and natural gas and is a hazard to oil and 
petroleum industry workers2, 11; in addition, sour oil pipeline explosion accidents have led to 
mass civilian casualties12. Rotting animal and plant matter as in sewer systems, animal 
manure from intensive animal agriculture, and waste products of food processing plants have 
also been sources of acute H2S poisoning13, 14.  In the Midwest, deaths of family members are 
reported due do acute H2S exposure following livestock manure pit agitation and pumping15, 
16. Because H2S is relatively easy to make at home from ingredients commonly available in 
retail stores, concerns exist about potential misuse of H2S as a chemical weapon, particularly 
in confined spaces such as underground train stations and high-rise buildings17, 18. Mass 
civilian exposure to H2S has occurred following industrial accidents, as was the case in Poza 
Rica, Mexico12, and following a sour oil pipeline explosion in Kaixian County, China:  the 
Poza Rica accident led to 22 deaths and hundreds were affected, and the Kaixian accident led 
to hundreds of civilian deaths and affected several thousands19.  
Acute inhalation exposure to high H2S concentrations affects the nervous, 
cardiovascular, and the respiratory systems20, 21. Death from acute H2S exposure arises from 
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cessation of breathing, due to inhibition of the respiratory center in the brain stem22, 23.  
During the Poza Riza and Kaixan industrial accidents, as well as during other occupational 
accidents, most deaths occur at the scene, but a substantial number of others die within 12 h 
after exposure12, 19. Of survivors discharged from the hospital with apparent recovery, many 
return 3-7 days post exposure complaining of neurological complications4, 24, 25.  These can 
include movement disorders, persistent migraines, memory loss, cognitive dysfunction, 
fatigue, hearing impairment, blindness, and seizures20, 25. Neurological sequelae usually 
occur in victims who have suffered a knockdown and have been on a coma for at least 5 
min2.  
Currently, no specific treatment exists for H2S poisoning, and because most deaths 
occur at the scene, there is an acute need for specific treatment in the field. Several 
approaches are used for treating patients in the hospital, including intravenous injections of 
sodium nitrite and hydroxocobalamin, oxygen supplementation, hyperbaric oxygen, and 
hypothermia15, 26-28. These modalities require intravenous access and specialized equipment, 
and are not suitable for field use. The ideal drug for field treatment should be easy to 
administer by first responders such as via intramuscular, sublingual, or transnasal routes. 
Cobinamide (Cob), a vitamin B12 precursor, has a high affinity for H2S and has shown 
promise in animal models of H2S poisoning increasing overall survival3. However, no data 
have been published on the efficacy of Cob for treating H2S-induced neurological sequelae.   
This study had two specific objectives. Objective #1 was to conduct a dose-response 
study to identify an ideal therapeutic dose of Cob for treatment of acute H2S poisoning. 
Objective #2 was to conduct a time-course study to determine the therapeutic window of 
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Cob, using a dosage chosen from Objective #1 above. We found that Cob markedly reduced 
H2S-induced neurotoxicity, neurodegeneration, and neurological sequelae in mice.   
Materials and Methods 
Chemicals and Reagents 
Methanol (HPLC grade), acetonitrile (HPLC grade), MD-TM mobile phase, and formic acid 
were obtained from Fisher Scientific (Waltham, MA). (D- and L-) Glutamic acid, γ-
aminobutyric acid (GABA), dopamine (DA), 3,4 dihydroxyphenlyacetic acid (DOPAC), 
homovanillic acid (HVA), norepinephrine (NE), 5-hydroxtryptaamine (5-HT), 5-
hydroxyindoleacetic acid (5-HIAA), paraformaldehyde, and 60% perchloric acid were 
purchased from Sigma Aldrich (St Louis, MO). All aqueous solutions were prepared using 
18.2 MΩ·cm water (Aries Filter Network, West Berlin, New Jersey, USA). Cobinamide was 
produced from hydroxocobalamin as described previously29. 
Animals 
All animal studies were approved by the Iowa State University Institutional Animal 
Care and Use Committee (IACUC). Only male mice were used in this study because 
previous studies showed that male are more sensitive to H2S-induced neurotoxicity than 
female mice30. The 7-8 week old C57/BL6 male mice were purchased from The Jackson 
Laboratories (Bar Harbor, ME), and weighed 20-25g at the beginning of the experiment. 
Mice were housed 5 per cage, in the Laboratory Animal Resource (LAR) Facility, Iowa State 
University College of Veterinary Medicine (ISU CVM, Ames, IA).  They were maintained at 
a controlled room temperature of 68-70°F, relative humidity of 35-50%, and a 12-hr 
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light/dark cycle. Mice were provided 14% Protein Rodent maintenance diet (Teklad HSD 
Inc, WI, USA), and drinking water ad libitum. These mice were acclimated to these 
environmental conditions for at least 1 week prior to the start of the experiments. 
Experiment 1: 
Determining an ideal efficacious cobinamide dosage for treatment of acute H2S-induced 
neurotoxicity 
In this dose-response experiment, we tested the hypothesis that Cob manifests dose 
response efficacy in a model of H2S-induced neurotoxicity and neurodegeneration.  To 
achieve this objective, we used a novel mouse model which was recently published30. 
Briefly, fully conscious and freely moving mice were placed in a whole-body exposure 
chamber designed to hold up to 10 mice at a time. Mice were exposed by whole body 
inhalation exposure. Gas access to the chamber was from two lines; one for breathing air 
from a tank under pressure, and the other from a tank containing H2S under pressure. The 
two lines connected to the chamber via a control panel that allowed regulation of both 
breathing air and H2S flow (liters/min).  The real-time concentration of H2S in the exposure 
chamber was constantly monitored using a H2S monitor (Environmental Equipment and 
Supply, Harrisburg, PA) that was custom designed to measure concentrations of up to 1000 
ppm of H2S. The H2S exposure paradigm used in this experiment is summarized in Figure 
1A. This exposure paradigm results in mice with behavioral, biochemical, neurochemical 
changes, and morphologic lesions recapitulating those of the human condition using a 
reasonably small number of mice to demonstrate the beneficial effects of countermeasures30. 
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  Mice were randomly divided into 4 different groups as follows: Group 1 mice were 
exposed to normal breathing air and injected with 0.9% saline; Group 2 mice were exposed 
to 765 ppm H2S and injected with 0.9% normal saline (Cob 0 mg/kg bw); Group 3 mice were 
exposed to 765 ppm H2S and injected with Cob at 50 mg/kg body weight; and Group 4 mice 
were exposed to 765 ppm H2S and injected with Cob 100 mg/kg body weight. Cob or 0.9% 
saline were injected in the rear leg muscle in 50 µL of solution. Normal breathing air or H2S 
were delivered from gas cylinders. On the first day, mice in groups of 10 were exposed to 
765 ppm H2S or breathing air for 40 min. On subsequent days, the same groups of mice were 
exposed either to 765 ppm H2S or to normal breathing air for 15 min only, each day. 
Following each exposure, the chamber was flushed out with breathing air for 2 min and 
injected with Cob or saline. All mice were euthanized 1 h after the last saline or Cob 
injection after the 7th exposure, except for mice designated for histopathological analysis 
which were euthanized 24 h after the 7th H2S exposure. End-points monitored included daily 
clinical assessment during and after H2S exposure using a modified functional observational 
battery (FOB)31. Other tests included behavior tests, neurochemical, biochemical, molecular, 
and histopathology endpoints. Number of animals used for each endpoint is summarized in 
Supplemental Table 2.  
Clinical Assessment 
         To obtain baseline data, animals were clinically evaluated and weighed daily starting 
3 days prior to H2S exposure. Following exposure, mice were weighed daily until euthanasia. 
A modified functional observational battery (FOB) was used for clinical evaluating during 
exposure in the chamber31. A clear advantage of this model employing freely moving 
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anaesthetized mice is that it allowed clinical assessment of mice during exposure. To assess 
the efficacy of Cob, clinical parameters evaluated included seizure activity and knockdown; 
which typically presented as lateral recumbency following seizure activity.  Time to seizure 
and knockdown was recorded. Other assessed parameters included lacrimation, salivation, 
piloerection, dyspnea, body posture, and gait.  For consistency, the same trained observer 
assessed the mice throughout the entire experiment. 
Behavior Tests 
Movement disorders are a common neurological sequela of acute H2S exposure in 
human beings25. To test the efficacy of Cob on coordination and balance, mice were 
subjected to the AccuRotor 4-Channel RotaRod test (rod diameter = 30 mm, height= 38 cm).  
Mice were trained on the rotating rod for two consecutive days prior to H2S exposure at 24 
rpm for 20 min. Following H2S exposure, mice were given 5 trials for 20 min at 24 rpm on 
test days 2, 4, and 6.   
Histopathology and Immunohistochemistry 
In humans, neurodegeneration is a common sequela of acute H2S poisoning. To 
evaluate this and the efficacy of Cob, designated mice were anesthetized deeply with a 
cocktail of 100 mg/kg bw ketamine and 10 mg/kg bw xylazine IM. Once in a surgical plane 
of anesthesia, the thoracic cavity was surgically opened to expose the heart. Fresh 4% 
paraformaldehyde solution (PFA, pH 7.4) was then injected through the left ventricle to 
perfuse the animal. After perfusion, brains were post-fixed in 4% PFA for 24 h, paraffin 
embedded, sectioned at 5 microns, and stained with hematoxylin and eosin for routine 
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histopathology. Additional brain sections were stained using an indirect immunostaining 
protocol (Vectastain Elite ABC kit, PK-6101, Vector Laboratories, Inc., Burlingame, CA) 
that employed primary antibodies directed at glial fibrillary acidic protein (GFAP, ab72600, 
Abcam), ionized calcium binding adaptor molecule 1 (Iba1, ab153696, Abcam), 4-
hydroxynonenal (4HNE; ab46545, Abcam). Diaminobenzidine (DAB, SK-4100, Vector 
Laboratories, Inc.) was the chromogen used. Stained sections were examined microscopically 
using a Nikon Eclipse Ci-L microscope with DS-Fi2 camera or EVOS FL fluorescence 
microscope. Routine histopathology, as well as immunohistopathology, was conducted by a 
board-certified veterinary pathologist blinded to the study design. Lesion severity was 
assessed using semi-quantitative scale summarized in Supplemental Table 1.  
Biochemical and Neurochemical Analysis 
Hydrogen sulfide inhibits cytochrome c oxidase activity and induces neurochemical 
changes by inhibiting the monoamine oxidase enzyme. These were used to assess the 
efficacy of Cob.  Mice were euthanized by decapitation 1 h after the last Cob injection. 
Brains were immediately removed from the skull, held on ice, and micro-dissected into 
different brain regions. Brain tissue samples were stored at -80 ºC until analysis. Cytochrome 
c oxidase enzyme was extracted from micro-dissected brain regions (inferior colliculus, 
thalamus, and cortex) and enzyme activity determined using an assay kit (ab109909) from 
Abcam (Cambridge, MA, USA) according to manufacturer’s protocol.   
To determine H2S-induced neurochemical changes, the striatum was analyzed for changes in 
dopamine (DA) and its metabolites, 3,4-Dihydroxyphenylacetic acid (DOPAC) and 
homovanillic acid (HVA).  The striatum was also analyzed for serotonin (5-HT), its 
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metabolite, 5-hydroxyindoleacetic acid (5-HIAA) as well as norepinephrine (NE). Samples 
were prepared and quantified as described previously30. Briefly, neurotransmitters were 
extracted from different brain regions in 0.2 M perchloric acid solution containing 0.05% 
Na2EDTA, 0.1% Na2S2O5, and isoproterenol (internal standard). DA, 5-HT, NE, and their 
respective metabolites were analyzed by HPLC ECD consisting of a CoulArray model 
5600A coupled with an analytical cell (microdialysis cell 5014B) and a guard cell (model 
5020). Neurochemicals and metabolites were separated isocratically by a reverse-phase 
column with a flow rate of 0.6 ml/min mobile phase (10% acetonitrile, 1% sodium 
phosphate, 89% water) using a Dionex Ultimate 3000 HPLC system (pump ISO-3100SD, 
Thermo Scientific, Bannockburn, IL) equipped with a refrigerated automatic sampler (model 
WPS-3000TSL). Data acquisition and analysis were performed using Chromeleon 7 and ESA 
Coularray 3.10 HPLC Software. 
Molecular Targets 
In order to elucidate the molecular effects of H2S-induced neurotoxicity and to 
evaluate efficacy of Cob as a therapeutic agent, the inferior colliculi from mice in the 
breathing air-control group, H2S-saline control, and H2S-Cob (100 mg/kg) mice were 
analyzed for gene and protein changes. First, a total RNA isolation protocol was adapted 
from Seo et al32. Briefly, brain tissue was placed in TRIzol Reagent, homogenized, and 
incubated for 5 min. Then, 200 µl of chloroform was added and shaken vigorously for 15 s. 
This mixture was incubated for 3 min and then centrifuged at 12,000 x g for 15 min at 4°C. 
The upper, aqueous layer was transferred to a separate tube and 500 µl of isopropanol was 
added. This suspension was incubated at RT for 10 min before being centrifuged for 10 min 
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at 4°C for 12,000 x g 32. First strand cDNA synthesis was performed using High Capacity 
cDNA Reverse Transcriptase Kit (Applied Biosystems, #4368814) following the 
manufacturer’s protocol. qRT-PCR was performed following previous protocols33. The 
following validated mouse primers were purchased from Qiagen and used for performing q 
RT-PCR: TNFα, IL-1β, IL-6, IL-12, and IL-18, TLR9, and MyD88. For normalization of 
each sample, the 18S rRNA gene (purchased from Qiagen) was used as the housekeeping 
gene. No-template controls (NTCs) and dissociation curves were run for all experiments to 
exclude cross-contamination 33. 
With the aim of studying protein changes via Western Blot, the inferior colliculus 
samples were lysed in modified RIPA lysis buffer (1% Triton X-100, 1mM EDTA, 100mM 
NaCl, 1mM EGTA, 1mMNaF, 20mM Na4P2O7, 2mM Na3VO4, 10% glycerol, 0.1% SDS, 
0.5% deoxycholate, 50mM Tris-Cl, pH7.4) via sonication. Brain homogenates were prepared 
as described previously34. Protein concentration of samples was measured using Bradford 
assay. Western blotting was performed as described previously 34. Briefly, the samples, 
containing equal amounts of proteins, were loaded and fractionated in a 10-12% SDS-PAGE 
gel and transferred onto a nitrocellulose membrane. Membranes were blocked with 5% milk 
in TBS supplemented with 0.1 % Tween-20 or Lico blocking buffer. Primary antibodies 
against specific proteins were incubated with the membrane overnight at 4°C. These included 
TNF-α receptor 2 (TNF-αR2, ab15563, Abcam), Caspase-3-cleavage (Santa Cruz 
Biotechnology), BCL2 associated death promoter (Bad, sc-943, Santa Cruz Biotechnology), 
and TNFα (R&D Biosystems). After rinsing thoroughly in PBS supplemented with 0.1% 
Tween-20, the membrane was incubated with Alexa Fluor 680 goat anti-mouse or IRDye 800 
donkey anti-rabbit secondary antibodies. For the loading control, β-actin antibody was used. 
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Immunoblot imaging was performed with an Odyssey Infrared Imaging system (LI-COR, 
Lincoln, NE, USA). ImageJ software (National Institutes of Health, Bethesda MD, USA) was 
used to quantify Western blot bands. 
Experiment 2: 
Determining the efficacious time window of cobinamide given post-H2S exposure  
A key question of any drug showing efficacy for treatment of H2S poisoning is how 
far out after rescue will the drug still benefit the patient. Under mass casualty conditions, 
some victims may not be reached for treatment 30-60 min post exposure. Using an effective 
Cob dosage chosen from Experiment 1 above, we tested the hypothesis that Cob at 100 
mg/kg bw is efficacious for treatment of H2S-induced toxicity given up to 30 mins post-H2S 
exposure.  The same H2S exposure paradigm as Experiment 1 was used for this study.  
Mice were randomly divided into 5 groups as follows: Group 1 mice were exposed to 
normal breathing air and injected with 0.9% normal saline 30 min post exposure; Group 2 
mice were exposed to H2S and injected with 0.9% normal saline 30  min post exposure; 
Group 3 mice were exposed to H2S and injected with Cob (100 mg/kg) 2 min post-H2S 
exposure; Group 4 mice were exposed to H2S and injected with Cob (100 mg/kg) 15 min 
post-H2S exposure; Group 5 mice were exposed to H2S and injected with Cob (100 mg/kg) 
30 min post-H2S exposure. Measured endpoints included clinical assessments using a 
modified functional observation battery, behavioral tests, neurochemical, biochemical, and 
histopathological endpoints as described under Experiment 1. All mice were euthanized 1 h 
post saline or Cob injection after the 7th exposure. 
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Data Analysis 
Data are presented as mean and standard error of the mean. Clinical toxicity during 
exposures was analyzed using linear regression. Biochemical and neurochemical endpoints 
were analyzed using a student’s t-test comparing the H2S-saline treated group to the H2S-Cob 
treated group. Behavioral data was analyzed using 2-way ANOVA with a Bonferroni post-
hoc test. Statistical tests were performed on Prism 6 (GraphPad Prism Software). Data was 
considered statistically significant at p<0.05.  
Results 
Experiment 1: Dose-response Cobinamide study 
Clinical assessment results 
Results of clinical assessment are summarized in Table 1. Mice exposed to normal 
breathing were normal and healthy throughout the duration of the study. Mice in the group 
exposed to H2S and treated with Cob were clinically better compared to mice exposed to H2S 
and treated with saline (Table 1). For example, mice exposed to H2S and injected saline 
exhibited typical clinical signs of H2S poisoning such as lacrimation, salivation, ataxia, 
impaired righting reflex, and convulsions which were absent in mice exposed to H2S and 
treated with Cob. However, all H2S dosed mice exhibited dyspnea characterized by open 
mouth breathing and hunched body posture, regardless of whether they were treated with 
Cob or not.  Mice exposed to H2S and injected with higher dosage of Cob at 100 mg/kg lost 
significantly less weight than those injected with saline. The lower Cob dosage at 50 mg/kg 
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dose did not prevent the H2S-induced weight loss (Fig 1B). However, Cob at 50 mg/kg and 
100 mg/kg increased survival in this model (Fig 1C).   
Over the course of the study, seizures were observed in about 80% of the mice 
exposed to H2S treated with saline, whereas only 5% of the Cob treated mice exhibited 
seizure activity (Fig 1D). Mice treated with the high dose of Cob (100 mg/kg) experienced 
significantly fewer knockdowns compared to the H2S-saline treated group, while the lower 
dosage Cob (50 mg/kg bw) did not protect against seizures as efficiently (Fig 1E). Overall, 
Cob at the 100 mg/kg dosage was more effective in countering clinical signs induced by H2S.    
Behavior Tests 
Results of the Rotarod test are summarized in Fig 1F. Cob at the higher dosage (100 
mg/kg bw), but not at the lower dosage (50 mg/kg bw), significantly protected mice against 
H2S-induced motor deficits.   
Histopathology and Immunohistochemistry 
 The inferior colliculus and the thalamus were the most consistently affected brain 
regions in this model.  Hydrogen sulfide-induced microscopic lesions consisted of vacuolar 
degeneration with formation of coalescing vacuoles in the neuropil, neuronal degeneration 
and cell death, and infiltration by activated neuroglia (Fig 2A).  In severely affected animals, 
there was complete loss of neurons in affected regions at 7 days, with increased numbers of 
astrocytes, microglia, and the presence of microglial phagocytic (Gitter) cells.  Capillaries 
within injured regions had prominent endothelial cells and were mildly tortuous, consistent 
with glial scar formation.  Cob at the highest dosage (100 mg/kg) significantly reduced the 
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severity of lesions in the inferior colliculus and thalamus, resembling control animals, while 
several of the animals treated with the lower dosage (50 mg/kg) developed degenerative 
lesions. These results showed that Cob at the higher dose was effective in reducing lesion 
severity and incidence than the lower dosage (Fig 2A-B).  
Biochemical and Neurochemical Analysis 
Previous work in our lab has found H2S to inhibit cytochrome c oxidase in multiple 
brain regions. We investigated cytochrome c oxidase activity in H2S-poisoned mice treated 
with saline versus those treated with Cob. Cytochrome c oxidase activity was significantly 
diminished in mice exposed to H2S and injected with saline, but was rescued in mice injected 
with Cob at 100 mg/kg. However, Cob at 50 mg/kg bw failed to rescue H2S-induced 
suppression of H2S-induced cytochrome c oxidase activity. This observation was observed in 
multiple brain regions including the inferior colliculus, thalamus, and the cortex (Fig 2C).  
Mice exposed to H2S and injected with saline showed a statistically significant 
increase in dopamine (DA) and its respective metabolites DOPAC and HVA. Cob at the 
highest dose (100 mg/kg bw) prevented the H2S-induced increase in DA, DOPAC, and HVA 
(Fig 2D).  
Molecular Targets 
We have previously reported that neuroinflammation is one of the mechanisms we 
hypothesize to be involved in H2S-induced neurotoxicity20.  Since Cob was most effective at 
100 mg/kg bw, in this portion of the study, we only investigated this dosage. Also, we 
focused on the inferior colliculus, the most consistently affected brain region in this model. 
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We found that TLR9 and MyD88 mRNA expression was significantly increased in the 
inferior colliculus of the H2S exposed mice treated with saline (Fig 3A).  Cob at 100 mg/kg 
bw prevented increased expression of TLR9 and MyD88 mRNA expression.  Activation of 
MyD88 by TLR9 can lead to NFkB activation, causing increased expression of pro-
inflammatory cytokines. Therefore, we investigated the effect of H2S on cytokines and the 
impact of Cob. Mice exposed to H2S and injected saline showed a significant increase in 
mRNA expression of TNF-α, IL-1β, IL-6, and IL-12. Cob at 100 mg/kg significantly lowered 
the expressions of these pro-inflammatory cytokines (Fig 3B). We also found upregulation of 
TNF-α receptor and TNF-α protein in mice exposed to H2S, but these TNF-related H2S-
induced changes were prevented in mice exposed to H2S and treated with 100 mg/kg Cob 
(Fig 3C). Increase in GFAP and Iba-1 protein typically reflects activated astrocytes and 
microglia indicating a neuroinflammatory response. H2S significantly increased the protein 
expression of GFAP and Iba-1 in the inferior colliculus, surrounding the lesion. This GFAP 
and Iba-1 H2S-induced increase was reduced by Cob (Fig 3D-E).  
Oxidative stress is another common mechanism of toxic induced neurodegeneration and is 
often coupled to inflammation. In this study, using Western Blot and immunohistochemistry 
analysis, we observed increased 4-HNE, a biomarker of lipid peroxidation in mice exposed to 
H2S and injected with normal saline (Fig 4A). Cob at 100 mg/kg prevented the generation of 
4-HNE, implying reduced oxidative stress. H2S also induced an increase of Bad protein, a 
pro-apoptotic protein, in the inferior colliculus; while Cob (100 mg/kg) reduced Bad 
expression (Fig 5B). We also found caspase-3 cleavage in mice exposed to H2S, which is 
indicative of apoptosis. This cleavage was prevented in mice exposed to H2S treated with 
Cob (Fig 4B).  
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  Collectively, results of this mechanistic data show that Cob is neuroprotective against 
H2S-induced inflammation, oxidative stress, and mitochondrial dysfunction. Overall, results 
of the dose response Cob study showed that Cob at 100 mg/kg bw was effective in treatment 
of H2S-induced neurotoxicity and neurodegeneration. 
We have previously reported that neuroinflammation is one of the mechanisms we 
hypothesize to be involved in H2S-induced neurotoxicity20.  Considering that Cob was most 
efficacious at the 100 mg/kg bw, in this portion of the study, we investigated the efficacy of 
Cob at this dosage. Also, we focused on the inferior colliculus, the most consistently affected 
brain region in this model. In these experiments, TLR9 and MyD88 mRNA expression was 
significantly increased in the inferior colliculus of the H2S-exposed mice treated with saline 
(Fig 3A), while Cob at 100 mg/kg bw prevented this increased expression of TLR9 and 
MyD88 mRNA expression.  Activation of MyD88 by TLR9 can lead to NFkB activation, 
causing increased expression of pro-inflammatory cytokines. Therefore, we investigated the 
effect of H2S on cytokines and the impact of Cob. Mice exposed to H2S and injected saline 
showed a significant increase in mRNA expression of TNF-α, IL-1β, IL-6, and IL-12. Cob at 
100 mg/kg significantly lowered the expressions of these pro-inflammatory cytokines (Fig 
3B). We also found upregulation of TNF-α receptor and TNF-α protein in mice exposed to 
H2S, but these TNF-related H2S-induced changes were prevented in mice exposed to H2S and 
treated with 100 mg/kg Cob (Fig 3C). Increase in GFAP and Iba-1 protein typically reflects 
activated astrocytes and microglia indicating a neuroinflammatory response. H2S 
significantly increased the protein expression of GFAP and Iba-1 in the inferior colliculus, 
surrounding the lesion. This GFAP and Iba-1 H2S-induced increase was reduced by Cob (Fig 
3D-E).  
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Oxidative stress is another common mechanism of toxic neurodegeneration and is 
often coupled to inflammation. In this study, using Western Blot and immunohistochemistry 
analysis, we observed increased 4-HNE, a biomarker of lipid peroxidation in mice exposed to 
H2S and injected with normal saline (Fig 4A). Cob at 100 mg/kg prevented the generation of 
4-HNE, implying reduced oxidative stress. H2S also induced an increase of Bad protein, a 
pro-apoptotic protein, in the inferior colliculus; while Cob (100 mg/kg) reduced Bad 
expression (Fig 5B). We also found caspase-3 cleavage in mice exposed to H2S, which is 
indicative of apoptosis. This cleavage was prevented in mice exposed to H2S treated with 
Cob (Fig 4B).  
  Collectively, results of this mechanistic data show that Cob is neuroprotective against 
H2S-induced inflammation, oxidative stress, and mitochondrial dysfunction. Overall, results 
of the dose response Cob study showed that Cob at 100 mg/kg bw was efficacious for 
treatment of H2S-induced neurotoxicity and neurodegeneration. 
Experiment 2: Therapeutic time window of cobinamide 
Clinical Assessment results 
In this portion of study, we used only the high dose of Cob (100 mg/kg bw). As 
observed in Experiment 1, mice treated with 100 mg/kg Cob injected 2 min post exposure, 
lost significantly less weight than the groups of mice injected with saline post H2S exposure 
throughout the 7 days of exposure. Body weights of the group of mice injected with Cob 15 
min or 30 min post H2S exposure were not significantly different from the group of mice 
exposed to H2S and injected with saline (Figure 5A).  However, H2S exposed mice injected 
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with Cob at 2 min and 15 min post exposure had a significantly greater cumulative survival 
rate compared to the mice injected with saline (Fig 5B). All mice that died during the 
experiment died during H2S exposure or within 5 min of termination of H2S exposure.  
Cob was most protective against seizure activity and knockdowns induced by H2S 
when given 2 min post exposure as opposed to at 15 or 30 min post-exposure. Cumulatively, 
by the 7th exposure, only about 10% of mice given Cob 2 min post exposure had seizures 
and knockdowns, which were significantly lower than that of H2S exposed mice injected with 
saline (60%). With respect to seizure activity, H2S-exposed mice given Cob 15or 30 min post 
H2S exposure were not protected and were not different than the H2S-saline treated group 
(Figure 5C-D).  
Behavior Tests 
Behavioral studies showed that motor deficits induced by H2S were significantly 
prevented by injecting Cob injected 2 min post exposure compared to the H2S group of mice 
injected with saline. Mice injected with Cob 15 and 30 min post H2S exposure did not 
perform significantly better than H2S-dosed mice injected with saline on the Rotarod test 
(Figure 5E). Overall, these behavioral results show that Cob is most efficacious against H2S-
induced toxicity if given 2 min post H2S exposure rather than 15 or 30 min post H2S 
exposure.  
Histopathology  
Control animals had no lesions.  Animals exposed to H2S consistently developed 
severe lesions in the inferior colliculus and mild lesions in the thalamus.  None of the mice 
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given Cob 2 min post H2S exposure developed moderate or severe lesions.  Twenty percent 
of mice treated with Cob at 15 min post H2S developed inferior colliculus injury with a 
histopathology score of >15 while 40 % of mice treated with Cob at 30 min post H2S 
developed inferior colliculus damage. Cob treatment at 15 or 30 min resulted in protection 
from neuronal degeneration and death, and reduced glial responses though best results were 
observed at 2 min.  Treatment with Cob at either 15 or 30 min post H2S exposure strongly 
protected against thalamic injury as did treating at 2 min post-H2S exposure. Results of the 
histopathology study suggest that injecting Cob 30 min post exposure was still beneficial in 
some mice, but best neuroprotection was achieved when treatment was given 2 min post-H2S 
exposure (Fig 6A-B). 
Biochemical and Neurochemical Analysis 
Here we investigated the effects of Cob on the H2S-induced inhibition of cytochrome 
C oxidase when the drug is administered at 2, 15 or 30 min post H2S exposure. Results 
indicate that Cob was most effective in preventing cytochrome C oxidase inhibition when 
given 2 min post exposure. Cob injected 15 or 30 min post exposure did not prevent H2S-
induced inhibition of cytochrome c oxidase enzyme in any of the brain regions examined, 
including the inferior colliculus, thalamus, and cortex (Fig 6D). 
As observed in Experiment 1, H2S induced an increase in dopamine in the striatum. 
Injecting Cob (100 mg/kg) 2, 15 and 30 min post H2S exposure prevented an increase in 
dopamine levels. Hydrogen sulfide DA-induced changes were most responsive to Cob 
therapy and giving Cob even 30 min out was still beneficial (Fig 6C).    
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Discussion 
This is the first study to evaluate the efficacy of Cob for treatment of H2S-induced 
neurodegeneration and other sequelae, and extends the work of others which focused on 
efficacy of Cob on enhancing survival3. We found that Cob is efficacious for treatment of 
H2S-induced neurodegeneration, and that 100 mg/kg Cob (Human equivalent dose = 8.1 
mg/kg) was most effective when given immediately after rescue from H2S exposure. At 50 
mg/kg Cob was not consistently effective across the suite of endpoints monitored in this 
study. This observation is borne out by results of percent survival, behavioral changes 
including prevention of body weight changes, rotarod tests, protection against neurochemical 
changes, protection against cytochrome C oxidase inhibition, preventing neural inflammation 
and oxidative stress, and reduction in neural lesion frequency and severity. As might be 
expected, delaying Cob injection post H2S exposure reduced its efficacy.  
Cobinamide is attractive for field treatment of H2S because it can be easily given by 
the IM route. Nitrite and hydroxocobalamin, the other drugs with reported efficacy for 
treatment of H2S poisoning require IV administration20, 35, which is cumbersome and 
inefficient for treating mass casualties. Besides, nitrite is associated with side effects such us 
hypotension, confounding H2S-induced hypotension20, 26. Hydroxocobalamin, though 
effective as a cyanide antidote, is not as effective as Cob in H2S animal models. Cob is 3-10 
times more potent than hydroxocobalamin in binding H2S35.  In this study we used 
dinitrocobinamide. This dissociates in vivo yielding Cob. One molecule of Cob binds 2 
molecules of sulfide unlike hydroxocobalamin which binds only one molecule35. It is also 
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possible that nitrite from dinitrocobinamide generates NO, with added benefit as does 
nitrite35.   
H2S dissociates into different sulfide species within a few minutes in vivo. Excellent 
studies by Haouzi et al., Jiang et al., Salnikov et al., and Cronican et al. suggest that 
following H2S exposure, < 50% of H2S exists in the parent form27, 28, 36. Considering this 
observation, it makes sense that Cob therapy would be most beneficial given during or a few 
minutes after termination of H2S exposure. It is during this time that Cob would combine 
with H2S before it transforms into other sulfide species. It is interesting however, that results 
from the time-course study (Experiment 2) showed Cob had some efficacy at 15 and even at 
30 min post H2S exposure. This suggests that Cob may harbor other mechanisms, which 
collectively contribute to its efficacy. Indeed H2S has been shown to induce oxidative stress 
via generation of superoxide anions and Cob has been shown to neutralize these free radicals 
3. Free radicals beget free radicals, triggering a chain reaction of oxidative stress and giving 
Cob as late as 15 min post-exposure may be beneficial by interrupting this process. We 
hypothesize that by binding H2S and neutralizing free radicles Cob protects critical molecular 
targets, resulted in reducing injury and associated inflammation. A recent case report of a 
human suicide victim of H2S by inhalation found the victim expired H2S for at least 7 h37.  If 
this is confirmed, the implication is that the window of opportunity for Cob therapy may 
actually be wider in some human cases. 
Seizure activity was significantly reduced or prevented by Cob. The mechanisms of 
H2S-induced seizures are unknown, but changes in neurotransmitters such as GABA and 
glutamate, and neural inflammation have been associated with seizures38. We did not 
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measure GABA and glutamate in this study, but we observed neuroinflammation. Cob at 100 
mg/kg reduced neuroinflammation and this potentially may have reduced seizure activity. 
Seizure severity has been linked to neural injury in other models of chemical-induced 
neurotoxicity such as nerve agents39.  Reducing seizure activity could be one way Cob 
reduced lesion severity.  Regardless of the mechanisms involved, results of this study have 
clearly shown that Cob reduced H2S-induced neurodegeneration.  
The role of H2S in inflammation is controversial both in vitro and in vivo40-43. H2S 
has been shown to increase pro-inflammatory cytokine expression in human monocytes via 
the ERK-NF-kappaB pathway44.  We showed that Cob ameliorates neuroinflammatory 
effects of H2S.in the inferior colliculus of mice. Furthermore, we showed that H2S caused an 
increase in TLR9 expression that caused increased MyD88 expression leading to 
transcription of pro-inflammatory cytokines via NFκ-B pathway.  We also found an increase 
in IL-6 expression. Increased IL-6 is a vital factor in vascular inflammation45, which is 
caused by monocyte infiltration in the injured vessel wall. In our model of H2S-induced 
neurodegeneration, H2S caused hemorrhage, in areas of the lesion, indicative of vascular 
damage; this was prevented by Cob.  
Frequently, TNFα is implicated in inflammation46. We found that both mRNA and 
protein expression of TNFα were increased in the H2S/saline group. This was significantly 
reduced by Cob. Under toxic conditions, microglia can release large amounts of TNFα46. 
Increased TNFα has been implicated in excitotoxicity by inhibiting glutamate transporters on 
astrocytes, increasing AMPA and NMDA receptors, while also decreasing GABA-A 
receptors on neurons38, 46. These mechanisms could be involved in the seizure-like activity 
92 
	  
that has been reported in human H2S exposure cases 47. Interestingly, we also found an 
increase in TNFαR2 that was significantly diminished by Cob. TNFαR2 is found 
predominantly in microglia, and found to mediate both pro-inflammatory and pro-survival 
signaling48. 
Release of pro-inflammatory cytokines (IL-1β, IL-6, IL-18, TNFα, and IL-12) from 
microglia can be toxic to neurons as they are rapidly upregulated when reacting to a toxic 
insult49. The pro-inflammatory cytokines propagate the inflammatory response and can cause 
neuronal and synaptic dysfunction49.  The neurons themselves can produce cytokines in 
response to the peripheral cytokines 50, which then sustains the neuro-inflammatory response 
(Scheme 1). Damaged neurons can also lead to the transformation of microglia into 
phagocytic cells that remove cellular debris51. It is important to note that Cob (100 mg/kg) 
injected 2 min post H2S exposure prevented these neuro-inflammatory changes from 
occurring.  
 Oxidative stress has been implicated in neuronal injury. In this model of H2S-induced 
neurodegeneration, oxidative stress can be caused by both the activated microglia51, but also 
directly from H2S. 4HNE is a biomarker of oxidative stress and has been implicated as a 
factor in mitochondrial dysfunction52. We found H2S increased the production of 4HNE, and 
Cob prevented this increase.  
 We found that H2S inhibited cytochrome c oxidase activity, a known hallmark of 
H2S-induced toxicity 53, 54. Low cytochrome c oxidase activity can result in a loss of 
membrane potential leading to production of oxidative stress55, 56 and mitochondrial 
dysfunction. Cob (100 mg/kg) prevented the inhibition of cytochrome c oxidase by H2S. We 
93 
	  
found that Bad was upregulated in H2S exposed brain tissue and Cob prevented the 
upregulation. Bad is a pro-apoptotic protein in the Bcl-2 family, a group of proteins that 
mediate pro- and anti-apoptotic signaling in the mitochondria56, 57. These results cumulatively 
show that Cob mitigates H2S-induced mitochondrial dysfunction. 
Mitochondrial dysfunction has been shown to lead to neurodegeneration58.  We found 
that H2S induces mitochondrial dependent apoptosis. Specifically, we found H2S induced 
caspase-3 cleavage in the inferior colliculus of H2S exposed mice and that Cob prevented this 
reaction.  
Collectively our data show proposed novel mechanisms of action for H2S-induced 
neurotoxicity. We have shown that H2S induced neuroinflammation resulting in production 
of many pro-inflammatory cytokines. This neuroinflammation leads to neuronal dysfunction 
in many ways, including excitotoxicity and oxidative stress inducing mitochondrial 
dysfunction, which can then propagate inflammation and also lead to neuronal cell death 
(Scheme 1).  Importantly, Cob (100 mg/kg) injected 2 min post exposure prevented these 
changes. We speculate since Cob binds directly to H2S preventing it from interacting with 
key molecular targets, thus  preventing  the clinical, pathological, neurochemical, and 
biochemical changes induced by H2S.  
Overall, results of this study show that Cob is protective against H2S induced 
neurotoxicity and neurodegeneration. Importantly, our data has revealed some of the 
mechanistic effects induced by H2S in a novel in vivo murine model, further identifying 
potential targets for therapeutic strategies. The inhalation model of H2S poisoning used here 
for evaluation of efficacy of Cob is not perfect. It has advantages as well as limitations. A 
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major advantage is that the route of H2S exposure is consistent with the route of exposure in 
humans. This model therefore replicates the pathophysiology implicated in human cases of 
inhalation H2S toxicity. With the convenient NaHS intraperitoneal injection model, death 
occurs within 5 min of injection and pulmonary edema is generally absent. In human H2S-
induced deaths, about 50% of victims die at the scene, but while most others die 12-24 h 
later12. This death pattern is not replicated by the NaHS.  A limitation of the model is that 
mice do not readily develop H2S-induced neurological lesions as humans do30. Single, acute 
high dose H2S causes high mortality during exposure, with only a few survivors developing 
neurodegeneration. Using a single, high dose exposure to mimic the typical human exposure 
scenario would have required an unreasonably large number of mice to test the efficacy of 
Cob. The approach used recapitulates H2S-induced neurodegeneration30. In conclusion, we 
have shown that Cob at 100 mg/kg bw is effective in treating H2S-induced 
neurodegeneration; it is best if given within 2 min of rescue, but still showed some efficacy 
up to 30 min post exposure. 
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Table 1.  Modified functional observational battery for evaluation of clinical signs during 
H2S exposure 
in the 
inhalation 
chamber. 
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Figure 1. Cobinamide dose-dependently prevented H2S intoxication.  H2S exposure paradigm 
in whole body inhalation chamber for 7 days (A). Cobinamide treatment prevented weight 
loss (B), mortality (C), seizure activity (D), and knockdown (E) following H2S exposure. * p 
< 0.05, slopes are significantly different from H2S saline group. Rotarod behavior testing 
post 2, 4, and 6 H2S exposure (F) ** p< 0.01 versus H2S-saline group.  
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Figure 2. Cobinamide was dose-dependently effective in preventing H2S neurotoxicity.  
Lesion severity was reduced following H2S exposure with treatment of Cob (50 mg/kg and 
100 mg/kg) (A-B). Prevention of cytochrome c oxidase activity inhibition (C) and 
neurochemical alterations (D) induced by H2S utilizing Cob (100 mg/kg) ** p< 0.01 versus 
H2S-saline group.  
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Figure 3. Cobinamide (100 mg/kg) prevented H2S-induced neuroinflammation in the inferior 
colliculus. Decrease in TLR9, MyD88, and pro-inflammatory cytokine mRNA expression 
with treatment of Cob post H2S exposure (A-B).  Downregulation of TNFαR2 and TNF-α 
protein levels with Cob treatment post H2S exposure (C). Reduction in activated microglia 
(D) and astrocytes (E) following treatment with Cob in H2S exposed mice. * p < 0.05, ** p < 
0.01 versus H2S-saline group.  
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Figure 4. Cobinamide (100 mg/kg) prevented oxidative stress and mitochondrial dysfunction 
induced by H2S exposure. Reduced 4-HNE production by cobinamide in the inferior 
colliculus post H2S exposure (A). Cobinamide prevented Bad upregulation and caspase-3 
cleavage induced by H2S (B). * p < 0.05 versus H2S saline group.  
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Figure 5. Cobinamide was effective in preventing clinical intoxication given 2 min post H2S 
exposure.  Weight loss (A), survival (B), seizure activity (C), and knockdown (D) during H2S 
exposure. * p < 0.05, slopes are significantly different from H2S saline group.  Rotarod 
behavior testing post 2, 4, and 6 H2S exposure (E) ** p< 0.01 versus H¬2S-saline group.  
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Figure 6. Overall, Cobinamide was most efficacious in preventing neurotoxicity given up to 
30 min post H2S exposure. Amelioration of H2S-induced lesion severity with Cob treatment 
up to 30 min post H2S exposure (A-B).  Cobinamide prevented increased DA levels induced 
by H2S up to 30 min post exposure (C). Inhibition of cytochrome c oxidase activity is 
prevented by administration of Cob 2 min post H2S exposure (D). * p < 0.05, ** p < 0.01 
versus H2S-saline group. 
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Scheme 1. A Proposed Mechanism: Cobinamide prevents the downstream effects of H2S –
induced neurodegeneration by binding to H2S to attenuate neuroinflammation, oxidative 
stress, and mitochondrial dysfunction.  
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Supplemental Table 1. Grading scheme for evaluation of histopathological lesions in the 
brain following H2S exposure in mice.   
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Supplemental Table 2. Summary of number of mice used per endpoint in experiments.  
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Abstract 
Introduction: Hydrogen sulfide (H2S), previously used as a chemical weapon, is a colorless, 
highly neurotoxic gas with a rotten egg odor. It is an occupational and an environmental 
hazard. Acute high dose exposure causes peracute death, while survivors develop 
neurological sequelae. Currently, there is no suitable antidote for treatment of H2S-induced 
neurotoxicity in the field. Midazolam (MDZ) is an anticonvulsant. Using a novel mouse 
model we tested the hypothesis that MDZ is effective in preventing and/or treating acute 
H2S-induced neurotoxicity.  
Methods: This proof-of-concept study had 2 main objectives: to determine whether MDZ 
prevents/reduces H2S-induced mortality when given pre-or post during H2S exposure; and to 
test whether MDZ prevents H2S-induced neurological sequelae. MDZ (4 mg/kg) was 
administered IM, 5 min pre exposure to one high concentration of H2S at 1000 ppm; or after 
12 mins after exposure to 1000 ppm H2S followed by a further 30 min exposure. A separate 
study tested the efficacy of MDZ  pretreatment using a mouse model of neurological 
sequelae. Breathing air and H2S controls were included in the study. Endpoints monitored 
included a functional observational battery used to assess clinical signs during H2S exposure, 
mortality, behavior changes, and histopathological changes.  
Results: Results indicated that MDZ given prophylactically or during H2S exposure 
significantly reduced H2S-induced lethality, seizures, knockdown, and behavioral deficits 
(p<0.01). MDZ also prevented H2S-induced weight loss, behavior deficits, 
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neuroinflammation, and histopathologic lesions (p< 0.01)in the thalamus and inferior 
colliculus.  
Conclusion: Overall, our findings show that MDZ is a promising drug for reducing H2S-
induced acute mortality, neurotoxicity, and neurological sequelae.   
 
Introduction 
Hydrogen sulfide (H2S) is an extremely toxic gas and is only second to carbon 
monoxide as a leading cause of gas-induced deaths. It is a hazard in many occupational 
settings where accidental acute high dose exposure may occur during regular work, following 
industrial malfunction, or because of malice. Mass civilian casualties of acute H2S poisoning 
have occurred in the past [1, 2]. Because if its history as a chemical weapon before, there is 
concern about potential misuse, especially in confined spaces such as the massive 
underground railroad system [3, 4]. At high concentrations, H2S rapidly exerts its toxic 
effects not only on the central nervous system, but also on the respiratory and cardiovascular 
systems [5, 6]. Clinical signs of acute H2S poisoning include dyspnea, anxiety, restlessness, 
and ocular and upper respiratory tract irritations in moderate concentrations. Sudden collapse 
(”knockdown”) accompanied by seizures and breathing difficulty from pulmonary edema, 
arrhythmia and hypotension are signs of acute exposure at higher concentrations.  
Hydrogen sulfide, which is characterized by a steep dose-response curve, causes high 
acute mortality. At least 50% of H2S-induced deaths occurring during exposure, while the 
remainder of the mortality of intoxicated victims occurs within 48 h of rescue [2]. A unique 
characteristic of this toxic gas is that the knockdown associated with sudden exposure to high 
concentrations is incapacitating, rendering the victims unable to escape [7]. Despite the high 
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mortality, some victims of acute H2S poisoning survive with or without supportive treatment. 
However, some of the survivors of acute intoxication develop long-term neurological 
sequelae characterized by psychiatric disturbances, persistent headaches, sleep disorders, 
anxiety, memory loss, learning disorders, hearing impairment, and movement disorders such 
as ataxia [5, 6, 8-10]. Neurological sequelae typically develop in victims, who succumb to 
knock down and coma, for as low as 5 mins but typically for 10-15 mins. These neurological 
complications may or may not be permanent but can be incapacitating, leading to work 
disability.  
Because most deaths occur at the scene, there is a critical need for a drug or drugs that 
can be used in the field for treatment of victims of acute H2S poisoning at the site. Currently 
recommended treatments of acute H2S-poisoning are of questionable efficacy and cannot be 
effectively in the field for treatment of mass casualties. For example, treatment 
recommendations include nitrite and hydroxocobalamin, both of which require intravenous 
(IV) injections [11-14]. Intravenous injections can be challenging to use in mass victims in 
the field. Besides, IV nitrite injections are associated with hypotension, a limiting side 
effect1. Hydroxocobalamin binds H2S, but large volumes of IV hydroxocobalamin are 
recommended. Cobinamide (Cob) is a promising H2S countermeasure that has shown 
efficacy in experimental animal models following intramuscular injection [14, 15] and can be 
delivered in the field. Nitrite, hydroxocobalamin, and cobinamide all largely work by binding 
H2S in vivo. Because H2S rapidly transmutes to other sulfide species, the therapeutic window 
for drugs that bind sulfide is very narrow. Consequently, there is a need to develop 
countermeasures with different mechanisms of action that can easily be used in the field for 
treatment of mass casualties.  
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Midazolam (MDZ), a common benzodiazepine and an anti-seizure medication, is on 
the list of The World Health Organization most essential drugs [16]. Available world-wide 
for treatment for epilepsy and seizures, this drug has recently shown promise as a 
countermeasure against nerve agent-induced neurotoxicity [16]. Midazolam is also a 
powerful anxiolytic, and has sedative and amnestic properties. Due to its rapid onset and 
relatively short half-life, MDZ is currently being considered to replace diazepam in the 
strategic defense stockpile as an anticonvulsant for nerve agent exposure [16]. It is very 
water soluble and therefore readily absorbed IM [16]. Maximum plasma concentration is 
reached in about 30 minutes post IM injection with > 90% bioavailability [16, 17]. Because 
of these desirable properties, we hypothesized that MDZ is effective for treatment of acute 
H2S-induced neurotoxicity. The objective of this proof-of-concept study was to conduct a 
series of experiments to test the hypothesis that MDZ is efficacious for treatment of acute 
H2S-induced mortality and neurotoxicity.  
 
Materials and Methods 
Animals 
All animal studies were approved by the Iowa State University Institutional Animal 
Care and Use Committee (IACUC). The 7-8 week old C57/BL6 male mice used in these 
studies were purchased from The Jackson Laboratories (Bar Harbor, ME) and weighed 20-
25g at the beginning of the experiment. Mice were housed 5 per cage, in the Laboratory 
Animal Resource (LAR) Facility of the Iowa State University College of Veterinary 
Medicine (ISU CVM, Ames, IA).  They were housed at a room temperature of 68-70°F, 
relative humidity of 35-50%, and a 12-hr light/dark cycle, and were provided 14% Protein 
115 
	  
Rodent maintenance diet (Teklad HSD Inc, WI, USA), and drinking water ad libitum. Mice 
were acclimated for 1 week prior to the start of the studies. 
Experimental approach 
In this proof-of-concept study we conducted a series of experiments to evaluate the 
efficacy of MDZ for prophylactic treatment (pre-H2S exposure) and for treatment of acute 
H2S exposure (during exposure). Fully conscious and freely moving mice were utilized. The 
mice were exposed to H2S by whole body inhalation exposure, details of which have 
previously been published[18]. Briefly, the experiments were conducted under a chemical 
fume hood approved by the Environmental Health & Safety at ISU. H2S was introduced to 
the chamber and the desired concentration achieved by dilution with normal breathing air 
from a gas cylinder.  The concentration of H2S in the exposure chamber was constantly 
monitored using a H2S monitor (Environmental Equipment and Supply, Harrisburg, PA) that 
was custom designed to measure concentrations of up to 1000 ppm of H2S.  
Objective 1: To test the efficacy of midazolam for reducing H2S-induced acute mortality 
Experiment 1: In this experiment we tested the hypothesis that injecting MDZ 
prophylactically before a single high dose H2S exposure reduced mortality. Mice were 
injected once, either with 0.9% saline or MDZ(4 mg/kg), IM 5 min prior exposure to 1000 
ppm H2S for 120 minutes (Fig1A).  
Experiment 2: In this experiment we tested the hypothesis that MDZ given once 
during acute high H2S exposure reduces H2S-induced mortality. Mice were exposed to 1000 
ppm H2S for 12 min in the inhalation chamber, after which mice were removed for injection 
of MDZ (4 mg/kg bw) or saline (0.9%) IM. All IM injections were 50 µL in the 
gastrocnemius muscle. Immediately after MDZ or saline injection, mice were returned to the 
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inhalation chamber for additional exposure to H2S (1000 ppm) for 30 min. Mice were 
constantly observed during exposure for clinical signs of intoxication using a modified 
functional observation battery (FOB) [18, 19]. Specifically seizure activity and time to death 
were noted (Fig 2A). This exposure paradigm was done to simulate rescue from underground 
confined spaces or from high-rise buildings where victim will be treated upon arrival of first 
responders, which was estimated to take about 10 mins; but complete evacuation may last 
another half an hour. The difference is that in our model, we removed the mice from the 
chamber to inject them because our exposure chamber is not designed to allow safe injections 
to be done while the mice are in the chamber. Mice were immediately returned to the 
chamber and H2S exposure immediately resumed. This procedure was completed within 5 
mins.  
Objective 2: To test the efficacy of midazolam for preventing neurological sequelae 
 In this proof-of-concept experiment we used a MDZ/H2S exposure paradigm 
summarized in Fig. 3A. Briefly, we tested the hypothesis that MDZ administered 
prophylactically 5 mins prior to H2S exposure prevents H2S-induced neurological sequelae. 
The justification for repeated short-term exposures has been provided in a prior publication 
[18]. Briefly, some of the human survivors of single acute high dose H2S poisoning develop 
neurodegeneration and other neurological sequelae. Whereas single high dose H2S exposures 
result in neurodegeneration in this mouse model, this approach is characterized by very high 
acute mortality during exposure, with only a few of the surviving mice developing 
neurodegeneration. Taking this single exposure approach, as occurs in humans, would 
require an unreasonably a large number of mice to test the hypothesis. We found repeated 
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short term acute H2S exposure to be more humane because it is associated with low 
mortality, and yet results in brain lesions recapitulating the human condition[18].   
Mice were divided into 3 different groups of 5 male mice as follows: Group 1 mice 
were injected with 0.9% saline 5 min before exposure to normal breathing air from a 
cylinder; mice in Group 2 were injected with 0.9% saline 5 min prior to exposure to 765 ppm 
H2S; Group 3 mice were injected with MDZ (4 mg/kg bw) 5 min prior to exposure to 765 
ppm H2S. MDZ or 0.9% saline were injected in the rear leg (gastrocnemius) muscle in 50 µL 
of solution. Normal breathing air and H2S were delivered from gas cylinders. In this H2S 
exposure paradigm, on day 0 mice in groups of 10 were exposed to 765 ppm H2S or 
breathing air for 40 min post injection of saline or MDZ as described above. On subsequent 
days, the same groups of mice were exposed either to 765 ppm H2S or to normal breathing 
air for 15 min only post injection with 0.9% normal saline, each day for 6 days.  
Clinical Assessment 
        To obtain baseline data in both experiments, animals were evaluated clinically and 
weighed starting 3 days prior to H2S exposure. Mice were weighed daily until euthanasia. In 
addition, a modified FOB was used to evaluate clinical signs during H2S exposure, including 
knockdown, seizure activity, abnormal gait, and autonomic function such as urination and 
defecation. The same trained observer assessed the mice throughout the entirety of the 
experiment. 
Behavioral Testing 
For behavioral assessment we used the VersaMax open field test. Behavior 
assessments for open field activity were performed 3 hours after mice were exposed to H2S. 
This was performed on days 2, 4, or 6 using a protocol adapted from Gosh et al [18, 20]. 
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Briefly, an automated computer-controlled device (Model RXYZCM-16; Accuscan, 
Columbus, OH, USA) was used to measure the spontaneous activity of mice in this open 
field test. The dimensions of the activity chamber were 40 × 40 × 30.5 cm, made of clear 
Plexiglas and covered with a Plexiglas lid with holes for ventilation. Data was collected and 
analyzed by a VersaMax Analyzer (Model CDA-8; AccuScan). Mice were acclimated to the 
chamber two days before H2S exposure. On test days, mice were placed inside the infrared 
monitor for 2 minutes to acclimate to the chamber. Open field activities were recorded for 
10-minute test sessions assessing multiple parameters including vertical activity and 
horizontal activity.  
Histopathology and Immunohistochemistry 
Mice designated for histopathology were euthanized 24 hours after the last H2S 
exposure using a previously published procedure that employed a cocktail of 100 mg/kg bw 
ketamine and 10 mg/kg bw xylazine given intraperitoneally [18]. Briefly, once the mice were 
in a surgical plane of anesthesia, the thorax was opened and fresh 4% paraformaldehyde 
solution (PFA, pH 7.4) was injected through the left ventricle to perfuse the animal. 
Thereafter, brains were post-fixed in 4% PFA for 24 hours, processed routinely, paraffin 
embedded, sectioned at 5 microns, and stained with hematoxylin and eosin for routine 
histopathology. Additional brain sections were stained using an indirect immunostaining 
protocol (Vectastain Elite ABC kit, PK-6101, Vector Laboratories, Inc., Burlingame, CA) 
that employed primary antibodies directed against glial fibrillary acidic protein (GFAP, 
ab72600, Abcam) or inducible nitric oxide synthase (iNOS, ab15323, Abcam). 
Diaminobenzidine (DAB, SK-4100, Vector Laboratories, Inc.) was the chromogen used. 
Stained sections were examined microscopically using a Nikon Eclipse Ci-L microscope 
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with DS-Fi2 camera. Routine histopathology was conducted by a board-certified veterinary 
pathologist blinded to the study design. The semi-quantitative scale used for scoring the 
severity of lesions has been previously published [5]. 
Objective 3: To test the effect of H2S on brain midazolam concentrations 
 During preliminary studies we observed clinical differences between mice injected 
MDZ with or without exposure H2S. Specifically, given equivalent dosages of MDZ, the 
sleeping time mice exposed to H2S was longer than that of mice without exposure to H2S. 
We hypothesized that high acute H2S exposure causes higher MDZ levels in brains mice 
exposed to H2S. In order to test this hypothesis two groups mice were exposed to 1000 ppm 
H2S for 20 min. They were then removed from the inhalation for chamber for 5 min during 
which mice were injected with 4 mg/kg bw midazolam. Mice were then placed back in the 
inhalation chamber for another 95 min (Fig 6A). A breathing air group of mice injected with 
saline was used as a negative control. Upon termination of H2S/breathing air exposure, mice 
were removed from the chamber, immediately decapitated and brain rapidly removed and 
placed on ice. After necropsy, brain tissues were subsequently stored at -80°C until ready for 
analysis. For this proof-of-concept experiment, only brain tissue was analyzed.  
Analysis of brain midazolam 
 Whole brain tissue samples were individually minced uniformly with scissors.  A 
0.1g brain tissue sample was weighed for extraction.  A matrix standard curve was also 
prepared using 4-0.1g control brain tissue samples containing 0, 0.1, 1, and 10 ng 
Midazolam. Midazolam was extracted according to Orkman et al., by adding 0.4 ml of 0.01 
N hydrochloric acid (HCl) to each sample. Each sample was then vortexed for 10 seconds, 
and sonicated for 5 minutes.  A 100 µL of 0.5N NaOH was subsequently added to each 
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sample and then vortexed for 10 seconds.  Samples were further extracted with 0.5 ml ethyl 
acetate and vortexed for another 10 seconds. Samples were then centrifuged at 20000 x g for 
5 minutes. The top layer of ethyl acetate was removed and placed into clean glass vials[21]. 
The ethyl acetate extraction was performed twice and the extracts combined. The combined 
extracts were then dried down under nitrogen, re-solvated in 200 µL methanol and vortexed 
for 10 seconds, before being quantified by LC-MS/MS,	  by injection of 20 µL out of the 200 
µL extract.  This analysis was performed on a Varian 310 LCMS triple quadrupole 
instrument using positive ESI with a needle voltage of (+) 3500, a shield voltage of (+) 600, 
drying gas temperature of 325°C, nebulizer gas at 50 psi and drying gas at 30 psi.  Detection 
ion used was 326-290.9 with a capillary voltage of 132 and collision energy of 21.5V.  
Confirmatory ion used was 326-244 with a capillary voltage of 132 and collision energy of 
20V.  Separation was performed on two Varian Prostar pumps equipped with a Varian 410 
autosampler usinga Polaris 5 micron C-18A column (150 x 2.0 mm) at a flow rate of 0.25 
ml/min. The mobile phase contained 60% 10 mM ammonium acetate and 0.1% formic acid 
in methanol and 40% 0.1 % formic acid.  Retention time of the Midazolam was 3.5 minutes 
[22, 23].   All samples were quantified against the matrix standard curve. 
Data Analyses  
Data are presented as mean and standard error of the mean. Clinical toxicity during 
exposures was analyzed using linear regression. Biochemical endpoints were analyzed using 
a student’s t-test comparing the H2S and saline treated mice to the H2S and midazolam 
treated mice. Behavioral data was analyzed using 2-way ANOVA with a post-hoc test. 
Statistical tests were performed on Prism 6 (GraphPad Prism Software).  
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Results 
Objective 1: Midazolam prevented H2S-induced mortality.  
Experiment 1: This experiment evaluated the efficacy of midazolam given pre-
exposure to H2S.  In this study 100 % of mice injected with saline and exposed to H2S 
experienced seizures and died (Fig 1B-C). In contrast, in the group of mice pretreated with 
midazolam, only 10% mortality was observed at the 2 hour time point when the experiment 
was terminated, with none of these mice experiencing seizures (Fig 1B-C).  
Experiment 2:   This study evaluated the efficacy of MDZ given during exposure to a 
single acute high dose of H2S. All of the mice exposed to breathing air and injected with 
0.9% normal saline survived. Compared to this group, only 25% of mice exposed to H2S and 
injected 0.9% normal saline survived (Fig 2B). Hydrogen sulfide-induced mortality was 
time- and concentration-dependent. However, in the group of mice exposed to H2S and 
treated with MDZ the survival rate was 100%, meaning none of the mice injected MDZ died 
(Fig 2A). Furthermore, none of the H2S exposed mice treated with MDZ manifested seizure 
activity compared to 40% in H2S /Saline group (Fig 2C).   
 
Objective 2: Midazolam prevented H2S-induced neurodegeneration and neurotoxicity 
During H2S-exposure, mice pretreated with MDZ and exposed to H2S were clinically 
healthy compared to mice treated with saline (Table 1). Specifically, saline pre-treated mice 
and exposed to H2S exhibited lacrimation, salivation, ataxia, impaired righting reflex and 
convulsions which were absent in mice pre-treated with MDZ. None of the mice pre-treated 
with MDZ manifested any seizures or knockdowns (Fig 3B-C). Midazolam also significantly 
122 
	  
prevented H2S-induced weight loss (Fig 3D). The weights of mice from H2S/MDZ group 
were statistically similar to those of saline/H2S group.  
In the open-field test, mice pre-treated with MDZ performed statistically significantly 
better overall than mice in the saline/H2S group on all days of testing. The vertical and 
horizontal activity of mice pre-treated with MDZ was better by 55% or greater compared to 
the H2S and saline group (Fig 3E).  
 Without MDZ pre-treatment, exposure to H2S consistently induced severe necrotic 
lesions in the inferior colliculus and thalamus, often with mild or moderate hemorrhage (Fig. 
4A-B).  Microscopically, the inferior colliculus of H2S-exposed mice showed extensive 
vacuolization of the neuropil, degeneration or loss of neurons, scattered apoptotic cell debris, 
influx and activation of microglia and astrocytes, and foci of hemorrhage in some animals. 
Pre-treatment with MDZ markedly reduced the incidence and severity of these neurologic 
lesions. The most consistent changes observed in the inferior colliculus or thalami of MDZ-
treated mice were minimal to mild enlargement and prominence of microglial nuclei and 
vacuolization of the neuropil. Lesions were not observed in animals exposed to breathing air.  
Subjective assessment of intensity and distribution of immunopositivity in GFAP- and iNOS-
immunostained sections revealed moderately increased expression of GFAP and iNOS in 
untreated, H2S-exposed mice and minimal to mildly increased GFAP and iNOS in MDZ-
treated animals (Fig. 5) 
Objective 3: H2S affects brain midazolam concentration 
 This experiment evaluated the effect of H2S on MDZ brain concentration. By 
measuring MDZ in brain tissue, we found that mice exposed to breathing air and injected 
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with MDZ had significantly less MDZ concentration in the brain than mice which were 
injected with MDZ and exposed to H2S (Fig 6).  
 
Discussion 
H2S is a rapidly acting, highly neurotoxic gas, with high acute mortality, usually at 
the scene of exposure. Currently, there is a need for drugs for treatment of victims of acute 
H2S intoxication in the field [7, 24]. This seminal proof-of-concept study has shown that 
prophylactic treatment with MDZ before H2S exposure and treatment with MDZ during H2S 
exposure significantly increases survival rate in mice exposed to lethal concentrations of 
H2S. The study also shows that prophylactic treatment with MDZ prevents H2S-induced 
neurodegeneration and neurological sequelae. These preliminary findings are significant 
considering there is no drug with such properties now currently on the market. The 
mechanism by which MDZ was able to do this are not known and are beyond this concept 
study. MDZ, an anticonvulsant drug, likely works by quieting neuronal activity.  Until now, 
other therapeutics being evaluated or recommended for treatment of acute H2S poisoning, 
including nitrite and hydroxocobalamin work by binding H2S in vivo.  Treatments that bind 
sulfides have the disadvantage that they are most efficacious if given during H2S exposure, 
because H2S rapidly dissociates into daughter sulfide species almost instantaneously in vivo. 
Optimal efficacy of such drugs occurs before H2S dissociates. It is not surprising, therefore, 
that the efficacy of nitrite for treatment of sulfide toxicity is questioned [5].  Midazolam, 
which is well absorbed IM and acts rapidly [16],  also has the advantage that it is currently 
approved as an anticonvulsant and is currently being considered for inclusion in the strategic 
defense stockpile for treatment of chemical induced seizures. Given the promising 
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preliminary results, repurposing MDZ for acute treatment of acute H2S poisoning is 
attractive.  
This preliminary data is encouraging because MDZ has significant potential for field 
application. For example, prophylactic treatment with MDZ could be an option for first 
responders before attempted rescue, as an added layer of security. Currently first responders 
use self-contained breathing apparatus in rescue missions to avoid intoxication. Sometimes 
these get dislodged and first responders get exposed to H2S [25, 26]. MDZ, in appropriate 
doses, MDZ could potentially serve as an added layer of protection.  
Its rapid absorption by IM route makes it particularly appealing, especially for 
treatment of mass civilian casualties during accidents or terrorist acts. Since convulsions are 
reported in severely affected victims of acute H2S poisoning, even post-H2S exposure, MDZ 
may potentially be useful for post-H2S exposure as an anticonvulsant.  Besides increasing 
survival, also significantly reduced H2S-induced neurodegeneration and resulted in improved 
behavioral performance. We also found MDZ pre-treatment consistently prevented 
knockdown and seizures induced by high acute exposures to H2S. The fact that MDZ 
pretreatment prophylactically prevented loss in body weight suggests these mice were 
clinically better than saline treated control mice.  
Histologic lesions observed in the brains of untreated animals exposed to H2S are 
consistent with those observed in our previous studies using a mouse inhalation model of H2S 
exposure that generates severe lesions and are similar to those reported in human patients 
[18].   Pre-treatment with MDZ reduced the development and severity of histologic lesions, 
reinforcing the clinical and behavioral observations in these mice. Reduced induction of 
GFAP and iNOS, markers of astrocyte activation and inflammation, respectively, in animals 
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that were prophylactically pre-treated with MDZ supports the notion that MDZ prevents the 
induction of an astroglial response and activation of inflammatory pathways. We have 
previously shown that inflammation plays a role in H2S-induced neurotoxicity[18]. The 
mechanism of action by which prophylactic treatment with MDZ reduced mortality and 
neurodegeneration is not known and cannot be ascertained from this limited proof-of concept 
study. However, it has been reported that MDZ reduces seizure activity by binding to the 
gamma containing receptors leading to allosteric potentiation of GABA gated 
hyperpolarization of the cell, inhibiting excitability [16]. Although not determined for H2S, 
seizure activity has been linked to neurodegeneration following nerve agent exposure [27]. 
Reduced seizure activity is potentially one of the mechanisms by which MDZ was 
prophylactically neuroprotective in this study. 
Midazolam has also been used for treatment of critically ill patients suffering from 
pathologic effects of oxidative stress such as infection, hemodynamic instability, and hypoxia 
[28]. H2S-induced neurotoxicity is characterized by hemodynamic instability (hypotension) 
and hypoxia [29, 30]. H2S-induced neurotoxicity is also characterized by oxidative stress [5, 
15]. There is evidence supporting the inverse correlation between midazolam and reactive 
oxygen species [28]. Midazolam has been shown to interfere with the synthesis and release 
of nitric oxide and tumor necrosis factor-alpha [28]. Midazolam also exerts protective effects 
during oxidative stress through the activation of Protein Kinase B (Akt) via phosphorylation 
in neuronal cells. Akt phosphorylation plays an important role in cell proliferation and cell 
survival [28, 31]. Potentially these are some of the mechanisms worthy of investigating in 
future experiments.  
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Another interesting finding from this study is the potential interaction between H2S 
and MDZ. Exposure to lethal concentration of H2S increased brain MDZ concentration. The 
reasons(s) for this finding are not clear and cannot be determined from this study; but either 
H2S increased penetration of MDZ in the brain or it impaired MDZ metabolism. Whatever 
the reason, this finding has practical implications. Dose-response MDZ studies are needed to 
identify an ideal therapeutic dose. In this study we chose to use 4 mg/kg bw basing on results 
of preliminary studies and because it is almost equivalent to the human dosage corrected for 
surface area (ref). 
 This proof-of-concept study has some limitations. For example, data was collected 
using a small number of animals and only male mice were used. It will be helpful to repeat 
this study with a large number of mice of both sexes. Also, although results of prophylactic 
pretreatment with MZD have relevance for first responders, a major need is to rigorously 
evaluate the efficacy of MDZ for treatment of victims of H2S in the field. To this end, 
preliminary results showing increased survival, reduced seizure activity and reduced 
knockdown in mice injected MDZ during H2S exposure are very encouraging. Hydrogen 
sulfide is uniquely characterized by a steep dose response curve with high mortality during or 
soon after exposure as a major outcome. More research is needed to conclusively determine 
the efficacy of MDZ given during exposure; and to evaluate its efficacy post H2S-exposure. 
Appropriate dose-response MDZ studies are also need. Considering that the toxicity of H2S is 
uniquely characterized by high mortality during exposure, reducing mortality by injecting 
MDZ during exposure will be a significant contribution towards treatment of acute H2S 
poisoning.  
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In summary, in this mouse model, MDZ treatment reduced mortality, seizure activity, 
behavioral deficits, and was neuroprotective against H2S-induced neurotoxicity. Results also 
indicated potential interaction between acute H2S exposure and MDZ as brain MDZ 
concentrations were significantly higher in H2S-exposed mice than those that were not. MDZ 
is a promising novel drug for treatment of acute H2S-induced neurotoxicity and 
neurodegeneration. Considering that it reduced acute mortality, reduced seizures and knock 
down given during H2S exposure is very appealing and further research is recommended to 
test the efficacy of MDZ for this purpose. 
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Figure 1. A) Treatment paradigm to determine the prophylactic efficacy of midazolam. B) 
Midazolam prevented H2S-induced mortality by 90%. n=10. C) Midazolam prevented H2S 
induced seizure activity in mice. n=10.  
 
 
131 
	  
 
Figure 2. A) Treatment paradigm to determine the efficacy of midazolam for treatment of 
H2S-induced neurotoxicity given during H2S exposure. B) Following Midazolam treatment 
no more mice died compared to about 20% survival for saline treated mice n=20. C) 
Midazolam abolished H2S induced seizure activity in mice. n=20  
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Table 1. Functional Observational Battery comparing mice injected with saline or midazolam 
prior exposure to H2S.  
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Figure 
3. A) Summary treatment paradigm H2S-induced neurological sequelae in mice 
prophylactically treated with MDZ. B) Midazolam completely prevented seizure activity and 
knockdown consistently during the entire exposure period n=5. C) Mice exposed to H2S and 
injected with saline lost statistically significant more weight compared to the breathing air 
controls injected with saline. MDZ prophylactically prevented H2S induced weight loss n=5. 
D) MDZ prevented H2S induced motor deficits n=5.  
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Figure 4. Photomicrographs of lesions in the thalamus and inferior colliculus of mice 
prophylactically treated with MDZ prior to H2S.  Note the pallor and loss of neurons in the 
thalamus of the saline/H2S-exposed mouse. Note that brain tissue of the MDZ/H2S is similar 
to that of the saline/breathing air group. Severe changes in the inferior colliculus of the 
saline/H2S-exposed mice include marked vacuolization of the neuropil, degeneration and loss 
of neurons, and prominent glial response.  
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Figure 5.  Representative photomicrographs of immunohistochemical staining of the inferior 
colliculus demonstrating expression of glial fibrillary acidic protein (GFAP), a marker of 
astrocyte activation, and inducible nitric oxide synthase (iNOS), a marker for 
neuroinflammation.  Note the increased expression of GFAP and iNOS (brown chromogen 
deposition) in the brain of the Saline/H2S group, while levels of these markers in the brains 
of MDZ-treated animals have less immunostaining, suggesting less inflammation the MDZ-
treated group.   
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Figure 6. Midazolam concentration in the brain. Note the significantly higher MDZ concentration in 
mice exposed to high concentration of H2S compared to those without H2S exposure.  
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CHAPTER 5 
 
GENERAL CONCLUSIONS AND FUTURE DIRECTIONS 
 
In this section, there is an overview of the main results as described within the 
dissertation with an emphasis on future directions and impact of these conclusions. Key 
findings pertainingto the individual research chapters can be found in the “results” and 
“discussion” sections of the corresponding chapter.  
A Mouse Model for H2S-induced Neurotoxicity 
The first chapter highlights the many challenges associated with studying H2S-
induced neurotoxicity. At physiological concentrations, H2S is a gasotransmitter much like 
carbon monoxide and nitric oxide and can play a role in many normal singal transduction 
pathways in the brain 4, 8, 107, 108. At high, toxic concentrations, H2S is acutely toxic and can 
cause neurodegeneration and other neurological sequelae71, 109-111.  
Acute exposure to toxic levels of H2S can occur in many exposure scenarios. H2S can 
be realeased from a natural source such as thermal hot springs or volcanoes, or it can be man-
made24. Bacteria also have the ability to produce toxic concentrations of this noxious gas 
under anaerobic conditions, causing the release of H2S in environments such as a sewer 
system or in an agricultural settings25. H2S is utilized and released in many industrial settings 
including petroleum refineries, paper mills, rayaon textile productions, chemical 
manufacturing, and waste disposal, posing an enormous occupational hazard9, 112. H2S is a 
leading cause of acute death, second only to carbon monoxide among toxic gas induced 
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deaths5, 44. The use of H2S in industrial settings creates the potential for sudden release 
following industrial accidents and/or a targeted attack. Given that H2S can be easily 
manufactured from house hold chemicals, there is a significant concern for the use of H2S as 
a chemical weapon11. It is currently listed as a chemical of interest by the Department of 
Homeland Security28. H2S is heavier than air,  and has the potential to settle and accumulate 
in confined, low spaces, such as a subway stations4.  
The central nervous system is a major target for H2S-induced toxicity. At high levels 
(ranging from 500-1000 ppm), H2S can cause victims to rapidly collapse, commonly known 
as “knockdown”5. This prevents the victims from escaping the scene of exposure.  At levels 
of 1000 ppm or above, a couple breaths of H2S can cause immediate collapse and death. 
Victims exposed to high levels of H2S, especially those who have experienced a knockdown, 
can experience neurological problems including persistent headaches, nausea, seizures,  
memory impairment, motor deficits, sleep disorders, vision and hearing imapirment, among 
other symptoms48, 49, 52.  However, the molecular mechanisms of H2S-induced neurotoxicity 
remain poorly understood.  
H2S is known to inhibit cytochrome c oxidase, the fourth complex of the electron 
transport chain42. Although it was earlier assumed that this inhibition led to ATP depletion 
causing cell death, more recent studies speculate that while this mechanism may contribute to 
H2S-induced neurotoxicity, it might not be the only mechanism of action42.  
Currently, there is no suitable antidote for treatment of H2S-induced neurotoxicity, 
particularly one  that can be administered in a mass civilian casualty setting such as 
following an industrial accident or a chemical attack. Such an antitode, which is easy to 
139 
	  
administer by IM injection, is badly needed. Current treatments for H2S intoxication include 
sodium nitirite administration, hyperbaric oxygen therapy, and hypothermia71, 77. These 
treatments are not ideal for field use in a mass civilian exposure setting as they require 
administration by experienced medical staff. The relevant equipment is also only available 
within hospital settings. Furthermore, currently, there is no antidote for treatment of H2S-
induced neurotoxicity and neurological sequelae.   
In order to develop an antidote and elucidate the molecular mechanisms underlying 
H2S-induced neurotoxicity, it is vital to establish and validate animal models of H2S toxicity. 
In Chapter 2, we characterized a mouse model of H2S-induced neurotoxicity. As supported 
by previous studies, it is very challengingto produce neurological lesions that recapitulate the 
human condition following a single exposure. In order to tackle this challenge, we developed 
two mouse models; one using lethality as an endpoint to screen potential antidotes to reduce 
mortality; a second on short term repeated acute exposures to recapitulate H2S-induced 
neurodegeneration for evaluation of countermeasures against neurodegeneration and other 
sequelae.  
Our model, for the first time, has characterized the effects of H2S-induced 
neurotoxicity utilizing a whole body inhalation model, on unanesthetized mice. By doing 
so,we were able to recapitulate realistic human exposure scenarios. This is an advanatage 
over previously described models that used NaHS, a source of H2S, intraperitoneally to study 
the effects of H2S82. Limitation of other inhalation models include the requirement of 
anesthetizing the animals before administration of the toxin, because the anesthesia may also 
modulate the response to H2S44. This prevents monitoring of clinical signs such as seizures 
and knockdowns (two major clinical consequences of human H2S intoxication) in their 
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animal models.  Using our mouse models of H2S inhalation exposure, we have substantially 
contributed to the understanding of major molecular mechanisms of H2S-induced 
neurotoxicity, including the presence of neuroinflammation and oxidative stress. We have 
also discovered the neurochemical changes induced by H2S, which could be contributing 
factors to many of the symptoms described in human cases of H2S poisoning, including the 
seizure activity, dysphoria, motor impairment, and personality changes.   
Although we have characterized a mouse model of H2S-induced neurotoxicity, some 
disadvantages to this model do exist. In order to fully recapitulate the human exposure 
scenarios described above, a one exposure model would be ideal. One exposure to H2S did 
cause neurodegeneration in some mice, but this was also accompanied by a high mortaliity 
rate, thus requiring us to use a large number of mice for use in translational studies to test the 
efficacy of drugs that will prevent neurodegeneration. Our repeated short-term acute 
exposures model consistently manifested lesions in the same regions as a single exposure, but 
with significantly less mortality. 
Cobinamide as an antidote for H2S-induced neurotoxicity 
 The main objective of Chapter 3 was to use the mouse model developed and 
characterized in Chapter 2 to test the efficacy of cobinamide (Cob) as an antidote for H2S-
induced neurotoxicity. Importantly, we have shown that cob is effective in preventing clinical 
signs, neurochemical, biochemical, and histopathological changes induced by H2S. 
Furthermore, this study allowed us to identify novel key mechanistic changes that have not 
been implicated in H2S-induced neurotoxicity. 
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 Other groups have investigated the use of Cob as an antidote to cyanide toxicity86. 
Due to some similarities between cyanide and H2S, we investigated this precursor to 
cobalamin as a potential H2S antidote. Studies done thus far have shown Cob to reduce 
mortality induced by H2S44, here we revealed that Cob treatment post H2S exposure was 
protective in preventing the neurological damage caused by H2S.  
 In chapter 3, we aimed to optimize the dose of Cob as well as the time window when 
Cob can be given. For example, an existing treatment for H2S intoxication, sodium nitirite, 
has been shown to be efficacious when administered 2 min post exposure. This is a problem. 
Sinceit needs to be given intravenously this window of opportunity is not feasible for a mass 
civilian casualty scenario.  Cob has the advantage that it can be administered 
intramuscularily; and is suitable for rapid treatment of mass civilian casualties.   
 Our studies demonstrated that Cob given 2 min post exposure, at the 100 mg/kg dose 
is the most efficacious at preventing H2S-induced neurotoxicity in mice. While injecting Cob 
2 min post exposure is the most efficacious, we noted that Cob offered some protection even 
as far out as 30 min post exposure. We also found that 50 mg/kg dose was not efficacious.  
Mice exposed to H2S displayed clinical signs such as dyspnea, lacrimation, salivation, 
seizure activity, ataxia, and knockdown. When given Cob, very few of the mice exhibited 
seizure activity and knockdown, and only displayed mild ataxia.  
 In this study, we also further evaluated the mechanisms of H2S-induced neurotoxicity. 
The hallmark of H2S intoxication is cytochrome c oxidase inhibition. We showed that Cob 
significantly prevented this inhibition when administered 2 min post H2S exposure. 
Howevergiven 15 min or later, Cob did not prevent this specific inhibition. Further more, we 
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found that Cob prevented Casp-3 cleavage and upregulation of pro-apoptotic proteins 
induced by H2S. This not only demonstrates that H2S may have other mechanisms of action 
for the potentiation of cell death, but that Cob prevents this from occuring.  
 Seizure activity has been linked to neural injury in other models of chemical-induced 
neurotoxicity, and neuroinflammation. Cob reduced seizure activity via mechanisms that are 
yet to be investigated, could be a contributing factor in Cob’s efficacy. Another pathway that 
Cob could be involved in is as an anti-inflammatory. While the role of H2S in 
neuroinflammation is controversial, at these toxic levels, we demonstrated that H2S caused an 
increase in pro-inflammatory cytokine expression, dependent on the ERK-NFkB pathway. 
The pro-inflammatory cytokines can potentiate the neuroinflammatory response by causing 
neuronal and synaptic dysfunction, which can lead to neuronal cytokine secretion, this 
response can sustain inflammation leading to chronic neuroinflammation causing 
neurodegeneration. More importantly, our studies showed that Cob attenuates the 
neuorinflammation induced by H2S. Together, our studies have extended our understanding 
of mechanisms of action of H2S, and novel  potential mechanism of Cob as an antidote. Prior 
to our studies, Cob was thought only to act by binding H2S. Using our well characterized 
model, we were able to conclude that Cob is effective in preventing the neurodegeneration 
associated with H2S-induced toxicity. It is most efficacious when administered 2 min post 
exposure at a dose of 100 mg/kg, but was somewhat efficacious when administered 15 min or 
later post H2S-administration.  
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Midazolam prevents H2S-induced neurotoxicity 
The objective of Chapter 4 was to again use the model we characterized in Chapter 2 
to evaluate Midazolam as an antidote for H2S-induced neurotoxicity. Given our observation 
that the severity of seizures corelated with mortality, we hypothesized that an anticonvulsant, 
such as Midazolam, will prevent H2S induced death and potentially treat neurological 
problems associated with H2S exposure. Midazolam, which has a rapid onset makes it more 
appealing as an antidote. Midazolam is also very water-soluble, making it ideal for 
intramuscular injections75. The use of a midazolam to prevent H2S-induced neurotoxicity is 
novel, as midazolam would act via different mechanisms than simply binding H2S to excrete 
it.  
This study had multiple objectives; to test the hypothesis that midazolam prevents 
H2S-induced mortality when given prior to exposure, and reduces mortality given during 
exposure.  This seminal study showed midazolam not only prevented mortality induced by 
H2S, but also the neurodegeneration. Midazolam prevented knockdowns and seizure activity 
induced by high H2S exposure, but also significantly prevented the neurological lesions 
induced by H2S. Reduction of GFAP and iNOS, markers of inflammation, suggest that 
midazolam prevents the induction of inflammatory pathways induced by H2S.  
While we have demonstrated that midazolam prevents H2S-induced toxicity, the 
mechanism by which it does this is yet unkown.  Given that midazolam drastically reduced 
seizure activity induced by H2S, and neurodegeneration, there might be a potential of seizure 
activity observed in H2S victims and the neurodegeneration observed in the brain.  
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While this study demonstrates the efficacy of midazolam, it does have some 
limitations. Further studies would need to be conducted to show its efficacy post-H2S 
exposure. This study is still beneficial as first responders reponding to a scene where they 
may encounter H2S could add this to the existing protocol for avoiding intoxication. We have 
also shown its potential as a life saving drug given during H2S exposure. A major advantage 
of using midazolam is the fact that it has already been FDA approved89. The drug does not 
need to undergo extensive safety testing, which is the case with the previously mentioned 
cobinamide. Midazolam can be repurposed for treating H2S-induced neurotoxicity.   
Future studies to investigate the potential combination of midazolam and Cob given 
concurrrently for treatment of H2S-induced neurotoxicity are recommended. Given that both 
these drugs would have different mechanisms of actions, combining these drugs would likely 
increase the efficacy compared to either drug given alone. A limitation to using cobinamide 
alone at the 100 mg/kg bw dose is that it can be toxic at 2-4 times this dose44, combining the 
drug with midazolam can create a dose sparing effect that would make cobinamide safer to 
use as well.  
Overall, we have characterized a mouse model of H2S-induced neurotoxicity that can 
be used to screen and validate potential antidotes for treatment of the neurotoxicity, 
neurodegeneration, and neurological sequelae associated with H2S exposure. We have 
successfully utilized this model to screen two promising drug candidates, cobinamide and 
midazolam, which were efficacious in preventing neurodegeneration induced by H2S. The 
validated model is available for evaluation of other potential drug candidates. This novel 
model also allows exploration of mechanisms of H2S-induced toxicity.   
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NOMENCLATURE 
4-HNE= 4-hydroxynonenal 
AKT = Protein kinase B 
ANOVA = Analysis of variance 
cAMP = cyclic adenosine monophosphate 
Cob = Cobinamide 
CNS= central nervous system 
DAB = 3,3’-Diaminobenzidine 
DOPAC = 3,4-dihydroxyphenylacetic acid 
ERK= extracellular-signal-regulated kinase 
GABA = gamma-aminobutyric acid 
GFAP = glial fibrillary acidic protein 
H2S = hydrogen sulfide 
HPLC= high performance liquid chromatography 
HVA= homovanillic acid 
IBA1= ionized calcium-binding adapter molecule 1 
IHC= immunohistochemistry  
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IL = Interleukin 
ISU= Iowa State University 
iNOS= inducible nitric oxide synthase 
KD= knockdown  
L-DOPA= L-3,4-dihydroxyphenylalanine 
MDZ = Midazolam 
NMDA= N-methyl D Aspartate 
NO = Nitric Oxide 
PKA = protein kinase A 
qPCR= quantitative polymerase chain reaction 
ROS= reactive oxygen species 
RNS = Reactive nitrogen species 
TNFα= Tumor necrosis factor α 
 
 
 
 
147 
	  
References 
 
 
1. Moustafa, A. & Y. Habara. 2015. Hydrogen sulfide: a novel gaseous signaling molecule and 
intracellular Ca2+ regulator in rat parotid acinar cells. Am J Physiol Cell Physiol. 309: C480-490. 
2. Tan, B. H., P. T. Wong & J. S. Bian. 2010. Hydrogen sulfide: a novel signaling molecule in 
the central nervous system. Neurochem Int. 56: 3-10. 
3. Beauchamp, R. O., Jr., et al. 1984. A critical review of the literature on hydrogen sulfide 
toxicity. Crit Rev Toxicol. 13: 25-97. 
4. Guidotti, T. L. 1996. Hydrogen sulphide. Occup Med (Lond). 46: 367-371. 
5. Guidotti, T. L. 2015. Hydrogen sulfide intoxication. Handb Clin Neurol. 131: 111-133. 
6. Smith, R. P. 1997. Sulfide poisoning. J Toxicol Clin Toxicol. 35: 305-306. 
7. Snyder, J. W., et al. 1995. Occupational fatality and persistent neurological sequelae after 
mass exposure to hydrogen sulfide. Am J Emerg Med. 13: 199-203. 
8. Guo, W., et al. 2012. Hydrogen sulfide as an endogenous modulator in mitochondria and 
mitochondria dysfunction. Oxid Med Cell Longev. 2012: 878052. 
9. Arnold, I. M., et al. 1985. Health implication of occupational exposures to hydrogen sulfide. J 
Occup Med. 27: 373-376. 
10. Guidotti, T. L. 1994. Occupational exposure to hydrogen sulfide in the sour gas industry: 
some unresolved issues. Int Arch Occup Environ Health. 66: 153-160. 
11. DHS. 1997. Federal Register. 72: 65423. 
12. DHS. 2007. Appendix A: Chemicals of Interest List. In Federal Register, Vol. 2017. 
Department of Homeland Security. 
13. Han, Y., et al. 2005. Modulating effect of hydrogen sulfide on gamma-aminobutyric acid B 
receptor in recurrent febrile seizures in rats. Neurosci Res. 53: 216-219. 
148 
	  
14. Panthi, S., et al. 2016. Physiological Importance of Hydrogen Sulfide: Emerging Potent 
Neuroprotector and Neuromodulator. Oxid Med Cell Longev. 2016: 9049782. 
15. Chen, X., K. H. Jhee & W. D. Kruger. 2004. Production of the neuromodulator H2S by 
cystathionine beta-synthase via the condensation of cysteine and homocysteine. J Biol Chem. 279: 
52082-52086. 
16. Kimura, H., et al. 2005. Physiological roles of hydrogen sulfide: synaptic modulation, 
neuroprotection, and smooth muscle relaxation. Antioxid Redox Signal. 7: 795-803. 
17. Wang, M., et al. 2015. Hydrogen sulfide functions as a neuromodulator to regulate striatal 
neurotransmission in a mouse model of Parkinson's disease. J Neurosci Res. 93: 487-494. 
18. Warenycia, M. W., et al. 1989. Monoamine oxidase inhibition as a sequel of hydrogen sulfide 
intoxication: increases in brain catecholamine and 5-hydroxytryptamine levels. Arch Toxicol. 63: 
131-136. 
19. Lopez, A., et al. 1989. Peracute toxic effects of inhaled hydrogen sulfide and injected sodium 
hydrosulfide on the lungs of rats. Fundam Appl Toxicol. 12: 367-373. 
20. Kamat, P. K., A. Kalani & N. Tyagi. 2015. Role of hydrogen sulfide in brain synaptic 
remodeling. Methods Enzymol. 555: 207-229. 
21. Kimura, H. 2000. Hydrogen sulfide induces cyclic AMP and modulates the NMDA receptor. 
Biochem Biophys Res Commun. 267: 129-133. 
22. Zhou, Q. & M. Sheng. 2013. NMDA receptors in nervous system diseases. 
Neuropharmacology. 74: 69-75. 
23. Erlander, M. G. & A. J. Tobin. 1991. The structural and functional heterogeneity of glutamic 
acid decarboxylase: a review. Neurochem Res. 16: 215-226. 
24. Daldal, H., et al. 2010. Hydrogen sulfide toxicity in a thermal spring: a fatal outcome. Clin 
Toxicol (Phila). 48: 755-756. 
25. Hurwitz, L. & G. Taylor. 1954. Poisoning by sewer gas with unusual sequelae. Lancet. 266: 
1110-1112. 
149 
	  
26. Matias, N., et al. 2017. Release of hydrogen sulfide in a sewer system under intermittent flow 
conditions: the Eiceira case study, in Portugal. Water Sci Technol. 75: 1702-1711. 
27. Database, N. A. S. 2002. Manure Gas Dangers Fact Sheet, Vol. 2015: www.farmsafety.ca. 
Guelph. 
28. Gerasimon, G., et al. 2007. Acute hydrogen sulfide poisoning in a dairy farmer. Clin Toxicol 
(Phila). 45: 420-423. 
29. Yalamanchili, C. & M. D. Smith. 2008. Acute hydrogen sulfide toxicity due to sewer gas 
exposure. Am J Emerg Med. 26: 518 e515-517. 
30. Bronstein, A. C., et al. 2009. 2008 Annual Report of the American Association of Poison 
Control Centers' National Poison Data System (NPDS): 26th Annual Report. Clin Toxicol (Phila). 47: 
911-1084. 
31. Ruder, J. B., et al. 2015. Hydrogen sulfide suicide: a new trend and threat to healthcare 
providers. J Burn Care Res. 36: e23-25. 
32. Anderson, A. R. 2016. Characterization of Chemical Suicides in the United States and Its 
Adverse Impact on Responders and Bystanders. West J Emerg Med. 17: 680-683. 
33. Mc, C. L. & G. D. Clayton. 1952. Air pollution by hydrogen sulfide in Poza Rica, Mexico; an 
evaluation of the incident of Nov. 24, 1950. AMA Arch Ind Hyg Occup Med. 6: 199-213. 
34. Shivanthan, M. C., et al. 2013. Hydrogen sulphide inhalational toxicity at a petroleum 
refinery in Sri Lanka: a case series of seven survivors following an industrial accident and a brief 
review of medical literature. J Occup Med Toxicol. 8: 9. 
35. Nabeshima, Y., et al. 2016. Analysis of Japanese Articles about Suicides Involving Charcoal 
Burning or Hydrogen Sulfide Gas. Int J Environ Res Public Health. 13. 
36. Sams, R. N., et al. Suicide with hydrogen sulfide. Am J Forensic Med Pathol. 34: 81-82. 
37. Bartholomaeus, A. R. & V. S. Haritos. 2005. Review of the toxicology of carbonyl sulfide, a 
new grain fumigant. Food Chem Toxicol. 43: 1687-1701. 
150 
	  
38. Haritos, V. S. & G. Dojchinov. 2005. Carbonic anhydrase metabolism is a key factor in the 
toxicity of CO2 and COS but not CS2 toward the flour beetle Tribolium castaneum [Coleoptera: 
Tenebrionidae]. Comp Biochem Physiol C Toxicol Pharmacol. 140: 139-147. 
39. Reiffenstein, R. J., W. C. Hulbert & S. H. Roth. 1992. Toxicology of hydrogen sulfide. Annu 
Rev Pharmacol Toxicol. 32: 109-134. 
40. Fuller, D. C. & A. J. Suruda. 2000. Occupationally related hydrogen sulfide deaths in the 
United States from 1984 to 1994. J Occup Environ Med. 42: 939-942. 
41. Doujaiji, B. & J. A. Al-Tawfiq. 2010. Hydrogen sulfide exposure in an adult male. Ann Saudi 
Med. 30: 76-80. 
42. Rumbeiha, W., et al. 2016. Acute hydrogen sulfide-induced neuropathology and neurological 
sequelae: challenges for translational neuroprotective research. Ann N Y Acad Sci. 
43. Guidotti, T. L. 2010. Hydrogen sulfide: advances in understanding human toxicity. Int J 
Toxicol. 29: 569-581. 
44. Jiang, J., et al. 2016. Hydrogen Sulfide-Mechanisms of Toxicity and Development of an 
Antidote. Sci Rep. 6: 20831. 
45. Ago, M., K. Ago & M. Ogata. 2008. Two fatalities by hydrogen sulfide poisoning: variation 
of pathological and toxicological findings. Leg Med (Tokyo). 10: 148-152. 
46. Kage, S., et al. 1998. A fatal case of hydrogen sulfide poisoning in a geothermal power plant. 
J Forensic Sci. 43: 908-910. 
47. Hessel, P. A., et al. 1997. Lung health in relation to hydrogen sulfide exposure in oil and gas 
workers in Alberta, Canada. Am J Ind Med. 31: 554-557. 
48. Smith, R. P. & R. E. Gosselin. 1979. Hydrogen sulfide poisoning. J Occup Med. 21: 93-97. 
49. Tvedt, B., et al. 1991. Delayed neuropsychiatric sequelae after acute hydrogen sulfide 
poisoning: affection of motor function, memory, vision and hearing. Acta Neurol Scand. 84: 348-351. 
50. Tvedt, B., et al. 1991. Brain damage caused by hydrogen sulfide: a follow-up study of six 
patients. Am J Ind Med. 20: 91-101. 
151 
	  
51. Parra, O., et al. 1991. Inhalation of hydrogen sulphide: a case of subacute manifestations and 
long term sequelae. Br J Ind Med. 48: 286-287. 
52. Kilburn, K. H. 2003. Effects of hydrogen sulfide on neurobehavioral function. South Med J. 
96: 639-646. 
53. Riudavets, M. A., P. Aronica-Pollak & J. C. Troncoso. 2005. Pseudolaminar necrosis in 
cyanide intoxication: a neuropathology case report. Am J Forensic Med Pathol. 26: 189-191. 
54. Dirnagl, U., C. Iadecola & M. A. Moskowitz. 1999. Pathobiology of ischaemic stroke: an 
integrated view. Trends Neurosci. 22: 391-397. 
55. Cai, W. J., et al. 2010. Hydrogen sulfide induces human colon cancer cell proliferation: role 
of Akt, ERK and p21. Cell Biol Int. 34: 565-572. 
56. Yang, G., X. Sun & R. Wang. 2004. Hydrogen sulfide-induced apoptosis of human aorta 
smooth muscle cells via the activation of mitogen-activated protein kinases and caspase-3. FASEB J. 
18: 1782-1784. 
57. Yang, G., L. Wu & R. Wang. 2006. Pro-apoptotic effect of endogenous H2S on human aorta 
smooth muscle cells. FASEB J. 20: 553-555. 
58. Veeranki, S. & S. C. Tyagi. 2015. Role of hydrogen sulfide in skeletal muscle biology and 
metabolism. Nitric Oxide. 46: 66-71. 
59. Cheung, N. S., et al. 2007. Hydrogen sulfide induced neuronal death occurs via glutamate 
receptor and is associated with calpain activation and lysosomal rupture in mouse primary cortical 
neurons. Neuropharmacology. 53: 505-514. 
60. Yamamoto, H. 1989. Hyperammonemia, increased brain neutral and aromatic amino acid 
levels, and encephalopathy induced by cyanide in mice. Toxicol Appl Pharmacol. 99: 415-420. 
61. Truong, D. H., et al. 2006. Molecular mechanisms of hydrogen sulfide toxicity. Drug Metab 
Rev. 38: 733-744. 
62. Truong, D. H., et al. 2007. Prevention of hydrogen sulfide (H2S)-induced mouse lethality and 
cytotoxicity by hydroxocobalamin (vitamin B(12a)). Toxicology. 242: 16-22. 
152 
	  
63. Kurokawa, Y., et al. 2011. Involvement of ERK in NMDA receptor-independent cortical 
neurotoxicity of hydrogen sulfide. Biochem Biophys Res Commun. 414: 727-732. 
64. Kombian, S. B., et al. 1988. Effects of acute intoxication with hydrogen sulfide on central 
amino acid transmitter systems. Neurotoxicology. 9: 587-595. 
65. Garcia-Bereguiain, M. A., et al. 2008. Hydrogen sulfide raises cytosolic calcium in neurons 
through activation of L-type Ca2+ channels. Antioxid Redox Signal. 10: 31-42. 
66. Eghbal, M. A., P. S. Pennefather & P. J. O'Brien. 2004. H2S cytotoxicity mechanism 
involves reactive oxygen species formation and mitochondrial depolarisation. Toxicology. 203: 69-
76. 
67. Lund, O. E. & H. Wieland. 1966. [Pathologic-anatomic findings in experimental hydrogen 
sulfide poisoning (H2S). A study on rhesus monkeys]. Int Arch Arbeitsmed. 22: 46-54. 
68. Baldelli, R. J., F. H. Green & R. N. Auer. 1993. Sulfide toxicity: mechanical ventilation and 
hypotension determine survival rate and brain necrosis. J Appl Physiol (1985). 75: 1348-1353. 
69. Sonobe, T., et al. 2015. Immediate and Long-Term Outcome of Acute H2S Intoxication 
Induced Coma in Unanesthetized Rats: Effects of Methylene Blue. PLoS One. 10: e0131340. 
70. Napoli, A., et al. 2006. Full Recovery of Two Simultaneous Cases of Hydrogen Sulfide 
Toxicity. Hospotal Physician47-50. 
71. Hall, A. H. & B. H. Rumack. 1997. Hydrogen sulfide poisoning: an antidotal role for sodium 
nitrite? Vet Hum Toxicol. 39: 152-154. 
72. Hoidal, C. R., et al. 1986. Hydrogen sulfide poisoning from toxic inhalations of roofing 
asphalt fumes. Ann Emerg Med. 15: 826-830. 
73. Chen, K. K. & C. L. Rose. 1952. Nitrite and thiosulfate therapy in cyanide poisoning. J Am 
Med Assoc. 149: 113-119. 
74. Smith, R. P. & R. E. Gosselin. 1976. Current concepts about the treatment of selected 
poisonings: nitrite, cyanide, sulfide, barium, and quinidine. Annu Rev Pharmacol Toxicol. 16: 189-
199. 
153 
	  
75. Belley, R., et al. 2005. Hyperbaric oxygen therapy in the management of two cases of 
hydrogen sulfide toxicity from liquid manure. CJEM. 7: 257-261. 
76. Smilkstein, M. J., et al. 1985. Hyperbaric oxygen therapy for severe hydrogen sulfide 
poisoning. J Emerg Med. 3: 27-30. 
77. Asif, M. J. & M. C. Exline. 2012. Utilization of hyperbaric oxygen therapy and induced 
hypothermia after hydrogen sulfide exposure. Respir Care. 57: 307-310. 
78. Gunn, B. & R. Wong. 2001. Noxious gas exposure in the outback: two cases of hydrogen 
sulfide toxicity. Emerg Med (Fremantle). 13: 240-246. 
79. Whitcraft, D. D., 3rd, T. D. Bailey & G. B. Hart. 1985. Hydrogen sulfide poisoning treated 
with hyperbaric oxygen. J Emerg Med. 3: 23-25. 
80. Gill, A. L. & C. N. Bell. 2004. Hyperbaric oxygen: its uses, mechanisms of action and 
outcomes. QJM. 97: 385-395. 
81. Bitterman, N., et al. 1986. The effect of hyperbaric oxygen on acute experimental sulfide 
poisoning in the rat. Toxicol Appl Pharmacol. 84: 325-328. 
82. Haouzi, P., B. Chenuel & T. Sonobe. High-dose hydroxocobalamin administered after H2S 
exposure counteracts sulfide-poisoning-induced cardiac depression in sheep. Clin Toxicol (Phila). 53: 
28-36. 
83. Haouzi, P., et al. 2014. In vivo interactions between cobalt or ferric compounds and the pools 
of sulphide in the blood during and after H2S poisoning. Toxicol Sci. 141: 493-504. 
84. Fujita, Y., et al. A fatal case of acute hydrogen sulfide poisoning caused by hydrogen sulfide: 
hydroxocobalamin therapy for acute hydrogen sulfide poisoning. J Anal Toxicol. 35: 119-123. 
85. Chan, A., et al. 2015. Nitrocobinamide, a new cyanide antidote that can be administered by 
intramuscular injection. J Med Chem. 58: 1750-1759. 
86. Chan, A., et al. Cobinamide is superior to other treatments in a mouse model of cyanide 
poisoning. Clin Toxicol (Phila). 48: 709-717. 
154 
	  
87. Luo, Y., et al. 2014. Aggravation of seizure-like events by hydrogen sulfide: involvement of 
multiple targets that control neuronal excitability. CNS Neurosci Ther. 20: 411-419. 
88. Faingold, C. L., et al. 1992. Glutamate in the inferior colliculus plays a critical role in 
audiogenic seizure initiation. Epilepsy Res. 13: 95-105. 
89. Reddy, S. D. & D. S. Reddy. 2015. Midazolam as an anticonvulsant antidote for 
organophosphate intoxication--A pharmacotherapeutic appraisal. Epilepsia. 56: 813-821. 
90. Organization, W. H. 2013 
WHO Model List of Essential Medicines 
http://www.who.int/medicines/publications/essentialmedicines/en/, Ed. 
91. Levy, A., et al. 2004. Characterization of early plasma concentrations of midazolam in pigs 
after administration by an autoinjector. Biopharm Drug Dispos. 25: 297-301. 
92. Haut, S. R., S. Seinfeld & J. Pellock. 2016. Benzodiazepine use in seizure emergencies: A 
systematic review. Epilepsy Behav. 63: 109-117. 
93. Chong, W. S., et al. 2012. Midazolam protects B35 neuroblastoma cells through Akt-
phosphorylation in reactive oxygen species derived cellular injury. Korean J Anesthesiol. 62: 166-
171. 
94. Han, C., et al. 2015. A comparison of the effects of midazolam, propofol and 
dexmedetomidine on the antioxidant system: A randomized trial. Exp Ther Med. 9: 2293-2298. 
95. Morales, I., et al. 2016. Neuroinflammation and Neurodegeneration. In Update on Dementia. 
Moretti, D. V., Ed.: Ch. 02. InTech. Rijeka. 
96. Carson, M. J., et al. 2007. A rose by any other name? The potential consequences of 
microglial heterogeneity during CNS health and disease. Neurotherapeutics. 4: 571-579. 
97. Tansey, M. G., et al. 2008. Neuroinflammation in Parkinson's disease: is there sufficient 
evidence for mechanism-based interventional therapy? Front Biosci. 13: 709-717. 
155 
	  
98. Xiong, X. Y., L. Liu & Q. W. Yang. 2016. Functions and mechanisms of 
microglia/macrophages in neuroinflammation and neurogenesis after stroke. Progress in 
neurobiology. 142: 23-44. 
99. Panicker, N., et al. 2015. Fyn Kinase Regulates Microglial Neuroinflammatory Responses in 
Cell Culture and Animal Models of Parkinson's Disease. J Neurosci. 35: 10058-10077. 
100. Qin, L., et al. 2007. Systemic LPS causes chronic neuroinflammation and progressive 
neurodegeneration. Glia. 55: 453-462. 
101. Ghosh, A., et al. 2007. Selective inhibition of NF-kappaB activation prevents dopaminergic 
neuronal loss in a mouse model of Parkinson's disease. Proceedings of the National Academy of 
Sciences of the United States of America. 104: 18754-18759. 
102. Ghosh, A., et al. 2009. Simvastatin inhibits the activation of p21ras and prevents the loss of 
dopaminergic neurons in a mouse model of Parkinson's disease. J Neurosci. 29: 13543-13556. 
103. Bebarta, V. S., et al. 2017. Efficacy of intravenous cobinamide versus hydroxocobalamin or 
saline for treatment of severe hydrogen sulfide toxicity in a swine (Sus Scrofa) model. Acad Emerg 
Med. 
104. Eltzschig, H. K. & P. Carmeliet. 2011. Hypoxia and inflammation. N Engl J Med. 364: 656-
665. 
105. Kida, K. & F. Ichinose. 2015. Hydrogen Sulfide and Neuroinflammation. Handb Exp 
Pharmacol. 230: 181-189. 
106. Whiteman, M. & P. G. Winyard. 2011. Hydrogen sulfide and inflammation: the good, the 
bad, the ugly and the promising. Expert Rev Clin Pharmacol. 4: 13-32. 
107. Calderone, V., et al. Using hydrogen sulfide to design and develop drugs. Expert Opin Drug 
Discov. 
108. Olas, B. 2017. Hydrogen Sulfide as a "Double-Faced" Compound: One with Pro- and 
Antioxidant Effect. Adv Clin Chem. 78: 187-196. 
156 
	  
109. Anantharam, P., et al. 2017. A mouse model for evaluating countermeasures against 
hydrogen sulfide-induced neurotoxicity and neurological sequelae. Ann N Y Acad Sci 
110. Lindenmann, J., et al. 2010. Severe hydrogen sulphide poisoning treated with 4-
dimethylaminophenol and hyperbaric oxygen. Diving Hyperb Med. 40: 213-217. 
111. Matsuo, M., J. W. Cummins & R. E. Anderson. 1979. Neurological sequelae of massive 
hydrogen sulfide inhalation. Arch Neurol. 36: 451-452. 
112. Adgate, J. L., B. D. Goldstein & L. M. McKenzie. 2014. Potential public health hazards, 
exposures and health effects from unconventional natural gas development. Environ Sci Technol. 48: 
8307-8320. 
 
